{"text": "A total of 400 subjects were enrolled and were randomized to receive one of three doses of TD-5108 ( 15 mg , 30 mg , or 50 mg ) or placebo , administered once daily over a four - week period .", "label": "", "metadata": {}, "score": "27.385574"}
{"text": "The trial consisted of 99 patients who achieved syndromic remission from an index manic or mixed episode after receiving olanzapine plus valproate / lithium for 6 weeks .", "label": "", "metadata": {}, "score": "27.94152"}
{"text": "The subjects received placebo or one of three different doses of NKTR-118 ( 5 , 25 or 50 mg ) given as a single daily oral dose for a treatment period of four weeks , in addition to their opioid therapy .", "label": "", "metadata": {}, "score": "34.276184"}
{"text": "The subjects received placebo or one of three different dose cohorts ( 5 mg , 25 mg , and 50 mg given as a single daily oral dose ) for a treatment period of four weeks .", "label": "", "metadata": {}, "score": "34.78405"}
{"text": "After completing an encouraging open - label pilot trial ( 23 ) , we conducted a double - blind randomized placebo - con- trolled trial of NAC in cannabis - dependent adolescents .", "label": "", "metadata": {}, "score": "34.844505"}
{"text": "Following a two week drug - free run - in period , the subjects received either 4 mg prucalopride or placebo , given orally once daily before breakfast , for four weeks .", "label": "", "metadata": {}, "score": "34.899178"}
{"text": "A total of 22 subjects enrolled in the two studies ( 9 in relapse prevention , 13 in abstinence initiation ) , who were treated with between three 100 \u00b5g and five 400 \u00b5g doses over 12 weeks .", "label": "", "metadata": {}, "score": "35.073586"}
{"text": "Reist?C , ?Lai ?LY , ? Swann?AC , ?Grabowski?J : ? Citalopram?combined?with?behav- ioral?therapy?reduces?cocaine?use : ? a?double - blind , ? placebo-Clinical Guidance : N - Acetylcysteine for Cannabis - Dependent Adolescents In an 8-week double - blind randomized placebo - controlled trial for treatment - seek- ing cannabis - dependent adolescents , Gray et al . added N - acetylcysteine ( 1,200 mg twice a day ) to contingency management intervention and very brief weekly ces- sation counseling .", "label": "", "metadata": {}, "score": "35.45117"}
{"text": "This multicenter , randomized , double - blind , placebo - controlled trial ( LIN - MD-31 ) enrolled 803 subjects who received either a 266 mcg once daily dose of linaclotide or placebo for a 12 week period .", "label": "", "metadata": {}, "score": "35.984673"}
{"text": "Patients were randomized 1:1 to receive either 500mcg of linaclotide or placebo for 12 weeks .The trial also includes an additional 40-week , open - label follow - on study period , which is ongoing .", "label": "", "metadata": {}, "score": "36.351147"}
{"text": "Following a four - week drug - free run - in phase , the subjects received either 0.5 mg , 1 mg , 2 mg , and 4 mg of prucalopride or placebo given orally once daily for four weeks .", "label": "", "metadata": {}, "score": "36.712227"}
{"text": "The subjects received TD-1211 ( 0.25 mg , 0.75 mg , 2 mg , 5 mg , and 10 mg ) or placebo administered orally once - daily in addition to their opioid treatment for a two - week treatment period .", "label": "", "metadata": {}, "score": "36.774223"}
{"text": "This research was recently published in the American Journal of Psychiatry .Gray , KM et al . , A double - blind randomized controlled trial of N - actylcysteine in cannabis - dependent adolescents .", "label": "", "metadata": {}, "score": "37.077873"}
{"text": "This multi - dose , double - blind , randomized , placebo - controlled study enrolled 32 healthy subjects not receiving opioid therapy .The subjects received NKTR-118 ( in escalating doses up to 250 mg ) or placebo twice daily for seven days , with a single dose on the eighth day .", "label": "", "metadata": {}, "score": "37.16268"}
{"text": "The subjects were clinically stable patients receiving maintenance treatment with an approved sublingual dose of buprenorphine / naloxone at a daily dose of 8 mg or less for at least three months prior to entering the trial .", "label": "", "metadata": {}, "score": "37.22474"}
{"text": "This randomized , double - blind , placebo - controlled , repeat - dose , dose - ranging study enrolled 951 patients with CIC .Subjects received 0.3 mg , 1 mg or 3 mg of plecanatide , or placebo , for 12 weeks .", "label": "", "metadata": {}, "score": "37.56083"}
{"text": "Eligible participants were given adolescent - targeted cannabis information brochures ( 30 ) , were enrolled in a contingency man- agement intervention ( see below ) , and were randomly assigned to a treatment group .", "label": "", "metadata": {}, "score": "38.351433"}
{"text": "Lithium was more effective in preventing a new affective episode , with an average relapse rate of 40 % over 1 to 2 years compared with 60 % in the placebo group .", "label": "", "metadata": {}, "score": "38.473053"}
{"text": "Subjects in one group received four Probuphine implants plus daily placebo sublingual tablets , and subjects in the second group received four placebo implants plus daily sublingual buprenorphine / naloxone tablets ( 8mg / day ) .", "label": "", "metadata": {}, "score": "38.663155"}
{"text": "Research assessments of marijuana use and withdrawal and drug safety and tolerability will occur weekly through the treatment phase of the 8-week study .", "label": "", "metadata": {}, "score": "38.90741"}
{"text": "Safety results yielded a positive overall profile , and there was no indication of safety concerns resulting from interaction between Tetrodin and naltrexone .This double - blind , placebo - controlled study enrolled 14 subjects on stable methadone therapy , who received a regimen of 30 mcg Tetrodin or placebo via subcutaneous injection twice daily for 4 days , prior to initiation of withdrawal symptoms by naltrexone administration .", "label": "", "metadata": {}, "score": "39.181564"}
{"text": "Preliminary data after four treatment cycles suggested that Vivitrex plus psychosocial therapy produced a 50 % reduction in heavy drinking days compared to placebo injections plus psychosocial therapy .", "label": "", "metadata": {}, "score": "39.46198"}
{"text": "Treatments were administered in - clinic under various fed / fast conditions that produced the highest bioavailability for each drug .Data are from 32 subjects .", "label": "", "metadata": {}, "score": "39.72033"}
{"text": "An analysis of covariance model was used to test for differences in the proportion of days of cannabis use throughout treatment .Page 4 . TRiAl OF N - ACeTylCySTeiNe iN CANNABiS - DePeNDeNT ADOleSCeNTS 808 ?", "label": "", "metadata": {}, "score": "40.24163"}
{"text": "Braeburn Pharmaceuticals released results of a phase III study of Probuphine for the long - term maintenance treatment of opioid addiction .The study enrolled 177 subjects who were randomized to receive either the Probuphine implants or sublingual tablets for six months .", "label": "", "metadata": {}, "score": "40.41622"}
{"text": "Tohen M , Greil W , Calabrese JR , et al .Olanzapine versus lithium in the maintenance treatment of bipolar disorder : a 12-month randomized , double - blind , controlled clinical trial .", "label": "", "metadata": {}, "score": "40.606705"}
{"text": "After a 24 hour observation period confirming that the subject is not undergoing opioid withdrawal , subjects will randomly receive either 30 mg oxycodone or matching placebo over two consecutive days in a double - blind fashion .", "label": "", "metadata": {}, "score": "40.68633"}
{"text": "Subjects will be 100 outpatients seeking treatment for current cannabis dependence with no clinically significant medical or psychiatric disorders ( including substance use disorders or a positive drug screen for substances other than cannabis or nicotine ) .", "label": "", "metadata": {}, "score": "40.74505"}
{"text": "November 9 , 2009 .Ironwood Pharma and Forest Labs issued positive results from two phase III trials of linaclotide for chronic constipation .Both randomized , double - blind , parallel group studies evaluated linaclotide ( 133 mcg or 266 mcg ) versus placebo once daily for 12 weeks .", "label": "", "metadata": {}, "score": "40.787033"}
{"text": "The efficacy of NAC compared with placebo , along with con- tingency management and weekly brief cessation counseling , in fostering abstinence from cannabis was analyzed over the 8-week treatment and at the follow - up 4 weeks after end of treatment .", "label": "", "metadata": {}, "score": "40.790306"}
{"text": "The placebo - controlled , randomized , open - label safety study enrolled 299 subjects at 20 sites in the U.S. Subjects were given active treatment or placebo for an additional three weeks before entering into the 48-week open label safety portion of the study .", "label": "", "metadata": {}, "score": "40.814735"}
{"text": "The olanzapine treatment group had a significantly higher completion rate than the placebo group ( 21 % vs 7 % ) and a longer time until discontinuation ( 83 days vs 26 days ) .", "label": "", "metadata": {}, "score": "40.844505"}
{"text": "The primary endpoint was reached with statistical significance in both the 25 mg and 50 mg cohorts versus placebo .In the 25 mg dose cohort , subjects had an average of 5.1 SBMs during the first week of treatment as compared to 1.5 SBMs per week during the baseline period .", "label": "", "metadata": {}, "score": "41.29019"}
{"text": "Even in adults , investigation of pharmacotherapy for cannabis dependence has been limited , and no effective medica- tions have been identified ( 9 ) .", "label": "", "metadata": {}, "score": "41.37215"}
{"text": "A study by Tohen and colleagues 52 was the first trial to assess an SGA in bipolar maintenance .The 52-week randomized , double - blind , placebo - controlled study included 361 patients in symptomatic remission from a manic or mixed episode after open - label treatment with olanzapine .", "label": "", "metadata": {}, "score": "41.40539"}
{"text": "The results support the hypothesis that treatment with NAC , compared with placebo , when added to contingency management and brief cessation counseling , yields im- proved cannabis abstinence during treatment .", "label": "", "metadata": {}, "score": "41.421658"}
{"text": "2003;2:S57-S66 .Tohen M , Greil W , Calabrese JR , et al .Olanzapine versus lithium in the maintenance treatment of bipolar disorder : a 12-month randomized , double blind , controlled clinical trial .", "label": "", "metadata": {}, "score": "41.693626"}
{"text": "Method : ?In?an ? 8-week ? double - blind ? ran-domized ? placebo - controlled ? trial , ?treat- ment - seeking ? cannabis - dependent ?", "label": "", "metadata": {}, "score": "41.846237"}
{"text": "Pharmacokinetic data demonstrated a steady state serum buprenorphine concentration after a six - month treatment period .The open - label , pilot study enrolled 12 subjects with opiate - dependence , who were switched from daily sublingual buprenorphine to Probuphine .", "label": "", "metadata": {}, "score": "41.95461"}
{"text": "Data demonstrated that Zelnorm - treated subjects experienced significantly more complete spontaneous bowel movements than subjects receiving placebo did .The multinational , randomized , double - blind , placebo - controlled study enrolled 1,264 subjects .", "label": "", "metadata": {}, "score": "42.089386"}
{"text": "No other participants in either group discontinued medication because of adverse events .There A post hoc sensitivity analysis was performed on propor- tion of negative urine cannabinoid tests during treatment , using multiple methods to manage missing data and drop- out .", "label": "", "metadata": {}, "score": "42.16597"}
{"text": "The 25 mg dose also demonstrated a higher response rate through 12 weeks of treatment compared to placebo in patients with laxative inadequate response , a secondary endpoint .", "label": "", "metadata": {}, "score": "42.189636"}
{"text": "Only 2 % of subjects treated with lithium in the study by Bowden and colleagues 44 and 17 % of patients treated with lithium in the study by Calabrese and colleagues 45 completed the trials .", "label": "", "metadata": {}, "score": "42.454567"}
{"text": "The trials enrolled approximately 2,000 subjects .The first two studies ( ESENSE1 and ESENSE2 ) assessed the efficacy of 20 mg doses of nalmefene on excessive alcohol consumption and on the overall alcohol intake per month in a treatment cycle of 24 weeks .", "label": "", "metadata": {}, "score": "42.482147"}
{"text": "Subjects received TD 1211 5 mg for the first four days and then TD 1211 5 mg , 10 mg or 15 mg for the remainder of the treatment period , or placebo for all five weeks .", "label": "", "metadata": {}, "score": "42.75139"}
{"text": "Sachs G , Chengappa KN , Suppes T , et al .Quetiapine with lithium or divalproex for the treatment of bipolar mania : a randomized , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "42.874603"}
{"text": "Taking the above together , it seems that depending on the sample , 25 % to 50 % of bipolar patients are cross - sectionally under antidepressants , with almost half of them receiving tricyclics .", "label": "", "metadata": {}, "score": "43.042336"}
{"text": "Adolescents receiving N - acetylcysteine had more that twice the odds , compared to those receiving placebo , of having negative urine cannabinoid ( an active ingredient in marijuana ) test results during treatment .", "label": "", "metadata": {}, "score": "43.354538"}
{"text": "In reviewing placebo - controlled trials , there is no consensus on the maximum dose or duration of concomitant medications .Olanzapine studies allowed the use 4 mg / d of lorazepam from days 1 through 7 in one trial , and 2 mg / d from days 1 through 4 in a second trial .", "label": "", "metadata": {}, "score": "43.451416"}
{"text": "In a subgroup analysis of 68 patients with both syndromic and symptomatic remission upon study entry , combination therapy was associated with a significantly longer time until symptomatic relapse of a mood episode ( 163 days vs 42 days ) .", "label": "", "metadata": {}, "score": "43.5074"}
{"text": "Abstract 15 .Tohen M , Chengappa KNR , Suppes T , et al .Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy .", "label": "", "metadata": {}, "score": "43.85899"}
{"text": "In addition , lithium was associated with a higher frequency of tremor and diarrhea .Lithium versus olanzapine .Lithium was compared with olanzapine in a randomized , double - blind , controlled trial made up of 431 subjects in symptomatic remission from a manic or mixed episode after receiving open - label cotreatment with olanzapine and lithium .", "label": "", "metadata": {}, "score": "44.034355"}
{"text": "Review of medication diaries and weekly pill counts indicated that 95 % of dispensed NAC doses and 93 % of dispensed placebo doses were taken .", "label": "", "metadata": {}, "score": "44.06029"}
{"text": "The randomized , double - blind , placebo - controlled , multi - site trial enrolled 1,223 adult patients with CIC .Patients were randomized to receive 72mcg of linaclotide once per day , 145mcg of linaclotide once per day , or placebo once per day for 12 weeks .", "label": "", "metadata": {}, "score": "44.09681"}
{"text": "The subjects received one of three twice - daily doses of Amitiza ( 8 , 16 or 24 mcg ) or placebo .The primary endpoint was mean change in spontaneous bowel movements ( SBM ) from baseline after one week of treatment .", "label": "", "metadata": {}, "score": "44.17894"}
{"text": "Doses were 5.3 mg lower with olanzapine , 0.7 mg lower with risperidone , and 115 mg lower with quetiapine .39 - 41,43 Despite the reduced doses , clinical response favored polytherapy versus antipsychotic monotherapy .", "label": "", "metadata": {}, "score": "44.206055"}
{"text": "In another randomized trial , 94 people with fibromyalgia received either myofascial release ( a type of treatment that involves palpitation of the fascial tissue surrounding muscles ) or sham therapy for 40 sessions ( 20 weeks ) .", "label": "", "metadata": {}, "score": "44.408257"}
{"text": "McIntyre RS , Brecher M , Paulsson B , et al .Quetiapine or haloperidol as monotherapy for bipolar mania - a 12 week , double - blind , randomised , parallel - group , placebo - controlled trial .", "label": "", "metadata": {}, "score": "44.61747"}
{"text": "Bowden CL , Calabrese JR , McElroy SL , et al , for the Divalproex Maintenance Study Group .A randomized placebo - controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder .", "label": "", "metadata": {}, "score": "44.628716"}
{"text": "The drug was found safe and well tolerated .Study results were presented at the Digestive Disease Week 2003 Conference .The multi - center , randomized , placebo - controlled trial enrolled 242 subjects with occasional constipation and was designed to test the saftey and efficacy of SPI-0211 ( 24 mg ) twice daily .", "label": "", "metadata": {}, "score": "44.700195"}
{"text": "October 11 , 2010 .Synergy issued positive initial results from a phase IIa trial of plecanatide for the treatment of chronic constipation .This randomized , double - blind , placebo - controlled , dose - escalation , cohort - design , multi - center clinical trial enrolled 78 subjects who were dosed with placebo or plecanatide once - daily for 14 consecutive days at oral doses of 0.3 mg , 1.0 mg , 3.0 mg or 9.0 mg , respectively .", "label": "", "metadata": {}, "score": "44.831924"}
{"text": "31 Four agents have been FDA - approved for maintenance therapy in bipolar disorder : lithium , lamotrigine , olanzapine , and aripiprazole .In addition , valproate / divalproex is commonly used in clinical practice .", "label": "", "metadata": {}, "score": "44.837868"}
{"text": "When the same 4-step approach was encouraged among 22 outpatients taking olanzapine , weight gain over 7 months averaged 5.3 lb , which was 40 % to 60 % less than weight gain seen without a structured intervention .", "label": "", "metadata": {}, "score": "44.97948"}
{"text": "Two head - to - head studies of olanzapine and divalproex assessed their relative efficacy in the treatment of bipolar disorder .The initial dosing in both studies differed .", "label": "", "metadata": {}, "score": "45.158005"}
{"text": "Dr. Kevin Gray in the Department of Psychiatry at MUSC and his colleagues demonstrated that N - acetylcysteine given over the course of 8 weeks to adolescent marijuana users reduced their use of marijuana .", "label": "", "metadata": {}, "score": "45.169304"}
{"text": "This rigorous definition probably resulted in a more stable patient population .During the maintenance phase , aripiprazole was administered at a daily dose of 15 to 30 mg .", "label": "", "metadata": {}, "score": "45.73777"}
{"text": "Bowden CL , Grunze H , Mullen J , et al .A randomized double - blind , placebo - controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder .", "label": "", "metadata": {}, "score": "45.76751"}
{"text": "Data are negative concerning bipolar depression ( two unpublished studies ) .There is one positive maintenance RCT with ziprasidone as an adjunct to valproate or lithium [ 92 ] .", "label": "", "metadata": {}, "score": "45.81858"}
{"text": "A Hungarian study reported that 35 % of patients were on antidepressants and more than half of them on SSRIs , which implies a sustained wide use of tricyclics [ 143 ] .", "label": "", "metadata": {}, "score": "45.857063"}
{"text": "Baker R , Zarate C Jr , Brown E , et al .A three - week comparison of olanzapine versus risperidone in the treatment of bipolar mania : improvement in manic and depressive symptoms and treatment adherence .", "label": "", "metadata": {}, "score": "45.971024"}
{"text": "Individual medications versus placebo .Lithium .Much of the early research in bipolar maintenance therapy focused on lithium monotherapy and often showed impressive results .", "label": "", "metadata": {}, "score": "46.032036"}
{"text": "We investigated only one NAC dosing regi- men over only 8 weeks , and the study was conducted at a single university - based research clinic with a relatively small sample of older adolescents within a narrow age range who presented with low rates of psychiatric co- morbidity .", "label": "", "metadata": {}, "score": "46.051193"}
{"text": "PubMed .Kane JM , Quitkin FM , Rifkin A , Ramos - Lorenzi JR , Nayak DD , Howard A : Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness : a prospective , placebo - controlled comparison .", "label": "", "metadata": {}, "score": "46.090553"}
{"text": "A significantly larger percentage of patients who received combination therapy completed the trial ( 31 % vs 10 % ) .Time until discontinuation was also longer for the combination therapy group ( 111 days vs 82 days ) .", "label": "", "metadata": {}, "score": "46.15138"}
{"text": "Trials studying the efficacy of pharmacologic agents in acute mania have used several approaches .These include the analysis of individual medications versus placebo , active comparator trials , and combination therapy studies .", "label": "", "metadata": {}, "score": "46.155666"}
{"text": "PubMed .Yatham LN , Vieta E , Young AH , Moller HJ , Paulsson B , Vagero M : A double blind , randomized , placebo - controlled trial of quetiapine as an add - on therapy to lithium or divalproex for the treatment of bipolar mania .", "label": "", "metadata": {}, "score": "46.18036"}
{"text": "PubMed .Small JG , Klapper MH , Marhenke JD , Milstein V , Woodham GC , Kellams JJ : Lithium combined with carbamazepine or haloperidol in the treatment of mania .", "label": "", "metadata": {}, "score": "46.43602"}
{"text": "Contingency management .A twice - weekly contingency man- agement intervention , separately targeting participant retention and cannabis abstinence and modeled on established methods ( 24 ) , was implemented during the medication trial .", "label": "", "metadata": {}, "score": "46.529274"}
{"text": "Geddes JR , Burgess S , Hawton K , et al .Long - term lithium therapy for bipolar disorder : systematic review and meta - analysis of randomized controlled trials .", "label": "", "metadata": {}, "score": "46.577644"}
{"text": "August 10 , 2015 .Synergy Pharmaceuticals reported results from two phase III trials investigating two plecanatide treatment doses ( 3 mg and 6 mg ) , taken as a tablet once - a - day , in 1,337 adult patients with chronic idiopathic constipation ( CIC ) .", "label": "", "metadata": {}, "score": "46.673393"}
{"text": "We hypothesized that treatment with NAC , relative to placebo , when added to contingen-A Double - Blind Randomized Controlled Trial of N - Acetylcysteine in Cannabis - Dependent Adolescents Kevin M. Gray , M.D. Matthew J. Carpenter , Ph.D. Nathaniel L. Baker , M.S. Stacia M. DeSantis , Ph.D. Elisabeth Kryway , P.A.-C. Karen J. Hartwell , M.D. Aimee L. McRae - Clark , Pharm .", "label": "", "metadata": {}, "score": "46.709106"}
{"text": "However , the recurrence rate and time to any mood episode did not differ between groups .On analysis of secondary end points , olanzapine significantly prolonged the time to a manic episode compared with lithium .", "label": "", "metadata": {}, "score": "46.76983"}
{"text": "J Clin Psychopharmacol .PubMed .Kushner SF , Khan A , Lane R , Olson WH : Topiramate monotherapy in the management of acute mania : results of four double - blind placebo - controlled trials .", "label": "", "metadata": {}, "score": "46.807526"}
{"text": "Subjects were followed for an additional four weeks .A dose response relationship among all doses was observed in the primary endpoint , as well as in most secondary endpoints , although statistical significance was not achieved at the 5 mg or 20 mg doses .", "label": "", "metadata": {}, "score": "46.81202"}
{"text": "8 Lithium failed to delay time to a depressive episode in all 3 studies .Treatment emergent adverse events were more prevalent in the lithium group , including nausea , diarrhea , tremor , and somnolence .", "label": "", "metadata": {}, "score": "46.905724"}
{"text": "Divalproex was orally loaded at 20 mg / kg / d .The study by Tohen and colleagues 37 started olanzapine at 15 mg / d and used a standard - titration divalproex dose of 750 mg / d .", "label": "", "metadata": {}, "score": "47.12552"}
{"text": "The subjects received subcutaneous methylnaltrexone 12 mg either once daily ( QD ) or once every other day ( QOD ) or placebo for four weeks .", "label": "", "metadata": {}, "score": "47.25948"}
{"text": "J Clin Psychiatry .Tohen M , Ketter TA , Zarate CA , et al .Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission : a 47-week study .", "label": "", "metadata": {}, "score": "47.304386"}
{"text": "Drug : Placebo .Treatment consisted of two matching placebo tablets three times a day .Detailed Description : .Paracetamol is recommended as a first - line analgesic and antipyretic therapy in patients receiving short- and long - term oral anticoagulation , especially elderly patient .", "label": "", "metadata": {}, "score": "47.332153"}
{"text": "Lithium and olanzapine were both associated with notable side effects .Lithium caused significantly more insomnia and nausea , while olanzapine resulted in more weight gain ( 1.8 kg vs -1.4 kg ) and hypersomnia .", "label": "", "metadata": {}, "score": "47.42399"}
{"text": "Keck and colleagues 51 performed a post hoc analysis of the study by Bowden and colleagues .8 They stratified serum drug concentrations to assess whether any concentration level separated from placebo on primary end points .", "label": "", "metadata": {}, "score": "47.522697"}
{"text": "Participants in the NAC group had more than double the odds of negative urine cannabinoid tests during treat- ment compared with those in the placebo group .", "label": "", "metadata": {}, "score": "47.526917"}
{"text": "However , the placebo - corrected response rates were quite different in the quetiapine studies ( 26 % and 8 % ) .Oral loading in acute mania .", "label": "", "metadata": {}, "score": "47.609062"}
{"text": "Findings have consistently demonstrated a reduced rate of suicide attempts and completions during lithium maintenance treatment compared with patients who did not take lithium .46 - 49 An analysis of 34 trials that included 17,491 patients with major affective illnesses found that the overall rate of suicidal acts in the group without lithium was 3.1 % per year compared with 0.2 % per year among patients who received lithium treatment .", "label": "", "metadata": {}, "score": "47.637917"}
{"text": "Experimental : Paracetamol 3g / d .18 patients on stable warfarin therapy received a 10-day regimen of paracetamol 3g / d .", "label": "", "metadata": {}, "score": "47.74485"}
{"text": "The 4 mg dose showed a minimal benefit over 2 mg but a less favourable adverse events profile .Hence prucalopride 2 mg once daily was chosen as the optimal dose .", "label": "", "metadata": {}, "score": "47.746277"}
{"text": "The starting dosages were 10 and 15 mg / d , respectively .Although olanzapine separated from placebo at the end of each study , the starting dosage of 15 mg / d had a faster onset of action , separating from placebo at day 7 versus day 21 .", "label": "", "metadata": {}, "score": "47.748737"}
{"text": "A follow - up assessment was conducted 4 weeks after end of treatment .Urine cannabinoid testing ( U.S.Screening Source , Inc. , Louisville ) was conducted at all visits .", "label": "", "metadata": {}, "score": "47.77197"}
{"text": "The average weekly increase in SBM from baseline for subjects on placebo was 1.4 .In addition , when compared to placebo , there was a statistically significant reduction in time to first SBM and a statistically significant increase in the percentage of subjects who experienced an SBM within the first 24 hours for all groups treated with TD-5108 .", "label": "", "metadata": {}, "score": "47.83434"}
{"text": "Keck PE Jr , Versiani M , Potkin S , et al .Ziprasidone in the treatment of acute bipolar mania : a three - week , placebo - controlled , double - blind , randomized trial .", "label": "", "metadata": {}, "score": "47.837517"}
{"text": "TABLE 2 Summary of inpatient and outpatient behavioral modification trials .The inpatient setting can be an ideal location for behavior modification education .A retrospective analysis of 143 hospitalized patients taking olanzapine found that 4 simple diet changes significantly reduced inpatient weight gain over a 3-week period .", "label": "", "metadata": {}, "score": "47.958054"}
{"text": "Potkin SG , Keck PE Jr , Segal S , et al .Ziprasidone in acute bipolar mania : a 21-day randomized , double - blind , placebo - controlled replication trial .", "label": "", "metadata": {}, "score": "48.00099"}
{"text": "Treatment of acute manic episodes .The treatment of acute mania initially centered on mood stabilizers and typical antipsychotics including lithium , valproate / divalproex , carbamazepine , and chlorpromazine .", "label": "", "metadata": {}, "score": "48.005352"}
{"text": "Progenics reported positive results from a phase II trial investigating methylnatexone ( MNTX ) for the treatment of opiod - induced constipation .Results showed that an average of 60 % of subjects who received at least 5 mg had a bowel movement within four hours compared with less than 8 % at lower doses .", "label": "", "metadata": {}, "score": "48.01201"}
{"text": "November 23 , 2009 .Alkermes reported positive results from a phase III trial of XR - NTX for the treatment of opioid dependence .This randomized , multi - center study enrolled 250 subjects who were dependent on opioids and who had recently been detoxified and abstinent from opioids for a minimum of seven days prior to treatment initiation .", "label": "", "metadata": {}, "score": "48.064964"}
{"text": "Tohen M , Chengappa KN , Suppes T , et al .Relapse prevention in bipolar I disorder : 18-month comparison of olanzapine plus mood stabilizer versus mood stabilizer alone .", "label": "", "metadata": {}, "score": "48.073715"}
{"text": "Antidepressants are also prescribed as if there is a ' class effect ' present during the maintenance phase .The US data from non - hospitalized subjects with bipolar I disorder in 1995/1996 suggested that more than half of all subjects were receiving concomitant antidepressants , of whom nearly 50 % received selective serotonin reuptake inhibitor ( SSRI ) antidepressants and nearly 25 % received buproprion [ 140 ] .", "label": "", "metadata": {}, "score": "48.313866"}
{"text": "PubMed .McIntyre RS , Brecher M , Paulsson B , Huizar K , Mullen J : Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week , double - blind , randomised , parallel - group , placebo - controlled trial .", "label": "", "metadata": {}, "score": "48.59268"}
{"text": "Study 242 enrolled approximately 120 subjects who received ADL5945 ( 0.10 mg or 0.25 mg ) given twice daily ( BID ) or placebo over a four week period .", "label": "", "metadata": {}, "score": "48.594177"}
{"text": "( For more information on this complicated issue , see Why Does This Database Rely on Double - blind Studies ? )A substantial study marred by poor design ( specifically , far too many primary endpoints ) found equivocal evidence that L - carnitine , taken at dose of 500 mg three times daily , might be more effective than placebo for the treatment of fibromyalgia .", "label": "", "metadata": {}, "score": "48.63898"}
{"text": "Keck PE , Calabrese JR , McQuade RD , et al .A randomized , double - blind , placebo - controlled 26 week trial of aripiprazole in recently manic patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "48.735664"}
{"text": "Methods .We reviewed the available treatment data from randomized controlled trials ( RCTs ) and explored 16 ' agent class'/'treatment issue ' cases for bipolar disorder .", "label": "", "metadata": {}, "score": "48.967327"}
{"text": "10 In this trial , 44 people with fibromyalgia took 800 mg of SAMe or placebo for 6 weeks .Compared to the group taking placebo , those taking SAMe had improvements in disease activity , pain at rest , fatigue , and morning stiffness , and in one measurement of mood .", "label": "", "metadata": {}, "score": "49.039528"}
{"text": "Of these subjects , 42 had received subcutaneous methylnaltrexone in the prior trial and 40 had received placebo .Of the subjects who had prior MNTX the mean laxation response rates ( laxation within four hours ) were 45.5 % during the first month , 57.7 % in the second month , and 57.3 % in the third month .", "label": "", "metadata": {}, "score": "49.13078"}
{"text": "The percentages of subjects with more than three SCBM / week averaged over four and twelve weeks were 10.4 % and 9.6 % for placebo , 23.7 % and 19.5 % for Resolor ( 2 mg ) and 26.6 % and 23.6 % for Resolor ( 4 mg ) , respectively .", "label": "", "metadata": {}, "score": "49.131245"}
{"text": "Hirschfeld RM , Keck PE Jr , Kramer M , et al .Rapid antimanic effect of risperidone monotherapy : a 3-week multicenter , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "49.291332"}
{"text": "The primary efficacy endpoint was the change from baseline in spontaneous bowel movements ( SBMs ) during the first week of treatment .The numerical magnitude of change was 4.0 and 5.4 SBMs / week respectively in the two highest dose groups .", "label": "", "metadata": {}, "score": "49.381245"}
{"text": "Exploratory secondary abstinence outcomes numerically favored NAC but were not statistically significant .NAC was well tolerated , supporting its safety in cannabis - de- pendent adolescents .", "label": "", "metadata": {}, "score": "49.40444"}
{"text": "Data showed that re - treatment with prucalopride led to rapid and sustained symptom relief .The efficacy findings during four weeks of treatment were comparable to those during four weeks of re - treatment .", "label": "", "metadata": {}, "score": "49.49543"}
{"text": "The primary efficacy endpoint was the response profile based on the rate of urine drug screens that were free of opioids during the last 20 weeks of the 24-week double - blind treatment period .", "label": "", "metadata": {}, "score": "49.696033"}
{"text": "Exploratory secondary abstinence outcomes favored NAC but were not statistically significant .NAC was well tolerated , with minimal adverse events .This is the first randomized controlled trial of pharmacotherapy for cannabis dependence in any age group to yield a positive primary cessation outcome in an intent - to - treat analysis .", "label": "", "metadata": {}, "score": "49.741707"}
{"text": "2003;2:S57-S66 .Keck PE , Bowden CL , Meinhold JM , et al .Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy .", "label": "", "metadata": {}, "score": "49.805878"}
{"text": "All tablets will be identical in appearance .The identity of each treatment will be unknown to all study personnel and subjects .Subjects will also be asked to complete a money versus drug questionnaire at various time points after drug administration .", "label": "", "metadata": {}, "score": "49.849716"}
{"text": "A recent study by Allen and colleagues 12 examined 374 patients with mania and found that the efficacy of valproate was significantly higher than that of placebo beginning at 71.4 to 85.0 \u00b5g / mL and for all higher valproate levels .", "label": "", "metadata": {}, "score": "49.96497"}
{"text": "The minimum and maximum divalproex concentrations over the 52-week maintenance phase were 0.6 and 156 \u00b5g / mL , respectively .Study discontinuations were lower in subjects treated with divalproex than in the placebo group , and divalproex was associated with a significantly lower termination rate for recurrent mania or depression .", "label": "", "metadata": {}, "score": "50.020393"}
{"text": "Combination data are negative for paliperidone ( NCT00309686 ) , positive for asenapine ( NCT00145470 and NCT00145509 ) and negative for licarbazepine .Combination treatment studies in bipolar depression are equivocal [ 35 , 96 - 98 , 103 , 115 , 125 - 131 ] .", "label": "", "metadata": {}, "score": "50.03852"}
{"text": "yic.0000224797.74771 . be .PubMed .Suppes T , Hirschfeld RM , Vieta E , Raines S , Paulsson B : Quetiapine for the treatment of bipolar II depression : analysis of data from two randomized , double - blind , placebo - controlled studies .", "label": "", "metadata": {}, "score": "50.172054"}
{"text": "There was no difference in the rate of depressive episodes .The side effects seen more frequently with lithium were somnolence , nausea , and diarrhea .", "label": "", "metadata": {}, "score": "50.243065"}
{"text": "These estimates were derived from a previous trial of pharmacotherapy to complement con- tingency management targeting cocaine dependence ( 32 ) .Set- ting the type I error rate to 0.05 , a sample of 58 participants per treatment group was deemed necessary to yield 80 % power .", "label": "", "metadata": {}, "score": "50.261833"}
{"text": "Tohen M , Jacobs TG , Grundy SL , et al , for the Olanzapine HGGW Study Group .Efficacy of olanzapine in acute bipolar mania : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "50.395226"}
{"text": "Active comparator trials are useful in distinguishing the head - to - head efficacy of medications .Studies have compared lithium versus many mood stabilizers and antipsychotics , haloperidol versus all SGAs except for ziprasidone , and olanzapine versus risperidone and valproate / divalproex .", "label": "", "metadata": {}, "score": "50.39582"}
{"text": "In addition , statistically significant improvements ( 9.7 % ) in the incidence of diarrhea were observed in the 3 mg arm ( versus placebo incidence of 1.3 % ) .", "label": "", "metadata": {}, "score": "50.490917"}
{"text": "Tohen M , Calabrese JR , Sachs G , et al .Randomized , placebo - controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine .", "label": "", "metadata": {}, "score": "50.53348"}
{"text": "Bowden CL , Brugger AM , Swann AC , et al , for the Depakote Mania Study Group .Efficacy of divalproex vs lithium and placebo in the treatment of mania .", "label": "", "metadata": {}, "score": "50.541664"}
{"text": "10.1097/YIC.0b013e328080ca57 .PubMed .Vieta E , T'Joen C , McQuade RD , Carson WH , Marcus RN , Sanchez R , Owen R , Nameche L : Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate / lithium monotherapy : a placebo - controlled study .", "label": "", "metadata": {}, "score": "50.601963"}
{"text": "The pilot study was designed to test the efficacy and safety of mesalamine gel in subjects with mild to moderate distal ulcerative colitis .Subjects were included in this study based on a disease activity index greater than three .", "label": "", "metadata": {}, "score": "50.621162"}
{"text": "Full - text .Preclinical and prelimi- nary clinical studies further support a potential treatment role for NAC ( 14 - 21 ) .Other clinical studies suggest that NAC , via glutamate modulation and a number of other proposed mechanisms , may be efficacious across a variety of psychiatric conditions ( 22 ) .", "label": "", "metadata": {}, "score": "50.67226"}
{"text": "The risperidone polytherapy response rate included a CGI - I rating of much or very much improved , 40 while response rates in all other studies represent a 50 % reduction in YMRS score .", "label": "", "metadata": {}, "score": "50.684303"}
{"text": "Sachs GS , Grossman F , Ghaemi SN , et al .Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania : a double - blind , placebo - controlled comparison of efficacy and safety .", "label": "", "metadata": {}, "score": "50.770546"}
{"text": "At the baseline visit , comprehensive psychiatric and substance use diagnostic assessment ( 26 - 28 ) , physical examination , and laboratory testing ( urine pregnancy and drug tests ) were per- formed .", "label": "", "metadata": {}, "score": "50.90336"}
{"text": "Significantly increased adverse effects were weight gain and fatigue .Weight gain in the open - label phase was 3 kg , with an additional 1 kg gain that occurred during the double - blind phase .", "label": "", "metadata": {}, "score": "50.90959"}
{"text": "H Lundbeck released results from three phase III trials of nalmefene for the treatment of alcohol dependence .The trials enrolled 1,997 subjects .The first two placebo - controlled studies ( ESENSE1 and ESENSE2 ) assessed the efficacy of 20 mg doses of nalmefene on excessive alcohol consumption and on the overall alcohol intake per month evaluated over six months .", "label": "", "metadata": {}, "score": "50.95011"}
{"text": "In the adjusted primary analysis model , study week and the treatment - by - study week interaction were not signifi- ca nt .Models were additionally examined for possible confounding and effect modification of age , weight , gen- der , race , psychiatric comorbidities , and number of previ- ous cannabis quit attempts , revealing no significant con- founders or effect modifiers .", "label": "", "metadata": {}, "score": "50.963886"}
{"text": "Treatment consisted of two paracetamol 500 mg ( Doliprane \u00ae 500 mg , Sanofi - aventis , Paris , France ) tablets three times a day .", "label": "", "metadata": {}, "score": "50.983894"}
{"text": "10.4088/JCP.v67n0811 .PubMed .Sachs G , Chengappa KN , Suppes T , Mullen JA , Brecher M , Devine NA , Sweitzer DE : Quetiapine with lithium or divalproex for the treatment of bipolar mania : a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "51.002876"}
{"text": "Each subject will receive a single dose of one of the following 7 treatments : .Placebo , oxycodone 20 mg , oxycodone 40 mg , oxycodone 20 mg / naltrexone 0.001 mg , oxycodone 40 mg / naltrexone 0.001 mg , oxycodone 20 mg / naltrexone 0.0001 mg , oxycodone 40 mg / naltrexone 0.0001 mg .", "label": "", "metadata": {}, "score": "51.027035"}
{"text": "Among FDA - approved agents , onset varies from 3 to 21 days .11 Medication dosing and rate of titration can significantly affect clinical response and may increase the risk of side effects .", "label": "", "metadata": {}, "score": "51.041897"}
{"text": "PubMed .Vieta E , Suppes T , Eggens I , Persson I , Paulsson B , Brecher M : Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder ( international trial 126 ) .", "label": "", "metadata": {}, "score": "51.047913"}
{"text": "Over the 12 week study courses , relapse was prevented in 75 % of subjects , and abstinence was initiated in 58 % .At a 12 month follow - up observation , once antibody levels had dropped , no relapse - prevention subjects and 42 % of abstinence - initiation subjects remained free from cocaine use .", "label": "", "metadata": {}, "score": "51.078365"}
{"text": "Pharmacoepidemiological data are limited and usually concern established treatments such as lithium , valproate or antipsychotics , but they rarely concern non - established treatments such as newer antiepileptics .", "label": "", "metadata": {}, "score": "51.168583"}
{"text": "Lithium versus lamotrigine .Bowden and colleagues 44 and Calabrese and colleagues 45 compared lithium with lamotrigine in patients recovering from manic and depressive episodes .", "label": "", "metadata": {}, "score": "51.169106"}
{"text": "10.1111/j.1399 -5618.2004.00115.x .PubMed .Yatham LN , Paulsson B , Mullen J , Vagero AM : Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania .", "label": "", "metadata": {}, "score": "51.186966"}
{"text": "Bowden and colleagues noted that divalproex was associated with greater weight gain when the serum concentration rose above 125 \u00b5g / mL. 8 In the same study , lithium levels exceeding 1.5 mEq / L correlated with diarrhea and tremor .", "label": "", "metadata": {}, "score": "51.27839"}
{"text": "The primary efficacy measure was the odds of negative weekly urine cannabinoid test results during treatment among participants receiving NAC compared with those receiving placebo , in an intent - to - treat analysis .", "label": "", "metadata": {}, "score": "51.47631"}
{"text": "Baseline treatment data for the first 500 patients in the STEP - BD study ( 1998 to 1999 ) revealed that the second most common class of agents was antidepressants ( 40.6 % ) [ 139 ] .", "label": "", "metadata": {}, "score": "51.508186"}
{"text": "An open - label trial examining valproate oral loading ( 20 mg / kg / d ) showed a therapeutic serum level ( of 50 \u00b5g / mL or higher ) in patients within 24 hours .", "label": "", "metadata": {}, "score": "51.605526"}
{"text": "for the last 5 days ) .Rats then underwent cue - induced reinstatement of active lever pressing in the absence of NAC , to determine if preventing NAC - induced restoration of one or the other protein was sufficient to block the capacity of chronic NAC to inhibit reinstatement .", "label": "", "metadata": {}, "score": "51.6727"}
{"text": "Studies have shown that many pharmacologic agents are effective in the treatment of acute mania and bipolar relapse education .The duration of manic episodes is reduced by valproate / divalproex , lithium , chlorpromazine , carbamazepine , olanzapine , aripiprazole , risperidone , quetiapine , and ziprasidone relative to placebo .", "label": "", "metadata": {}, "score": "51.716057"}
{"text": "Effective treatments for bipolar disorder .Valproate has proven efficacy against acute mania [ 17 - 22 ] .One maintenance phase RCT was negative for valproate , however , it possibly suffered from a problematic study sample [ 27 ] .", "label": "", "metadata": {}, "score": "51.74568"}
{"text": "PubMed .McIntyre RS , Cohen M , Zhao J , Alphs L , Macek TA , Panagides J : Asenapine in the treatment of acute mania in bipolar I disorder : A randomized , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "51.759712"}
{"text": "February 19 , 2007 .Dynogen reported positive results from a phase II trial of DDP733 for the treatment of irritable bowel syndrome with constipation ( IBS - c ) .", "label": "", "metadata": {}, "score": "51.77102"}
{"text": "10.1016/j.pnpbp.2008.10.012 .PubMed .Arch Gen Psychiatry .10.1001/archpsyc.59.1.62 .Houston JP , Ahl J , Meyers AL , Kaiser CJ , Tohen M , Baldessarini RJ : Reduced suicidal ideation in bipolar I disorder mixed - episode patients in a placebo - controlled trial of olanzapine combined with lithium or divalproex .", "label": "", "metadata": {}, "score": "51.7735"}
{"text": "Finckh A , Berner IC , Aubry - Rozier B , et al .A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia .", "label": "", "metadata": {}, "score": "52.02879"}
{"text": "Schaffer A , Zuker P , Levitt A : Randomized , double - blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression .", "label": "", "metadata": {}, "score": "52.03624"}
{"text": "Keck PE Jr , Marcus R , Tourkodimitris S , et al .A placebo - controlled , double - blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania .", "label": "", "metadata": {}, "score": "52.041245"}
{"text": "10.1016/j.euroneuro.2005.02.006 .PubMed .Smulevich AB , Khanna S , Eerdekens M , Karcher K , Kramer M , Grossman F : Acute and continuation risperidone monotherapy in bipolar mania : a 3-week placebo - controlled trial followed by a 9-week double - blind trial of risperidone and haloperidol .", "label": "", "metadata": {}, "score": "52.09536"}
{"text": "10.1176/appi.ajp.159.7.1146 .PubMed .Chou JC , Czobor P , Charles O , Tuma I , Winsberg B , Allen MH , Trujillo M , Volavka J : Acute mania : haloperidol dose and augmentation with lithium or lorazepam .", "label": "", "metadata": {}, "score": "52.116814"}
{"text": "Two randomized controlled trials have shown valproate / divalproex to be effective in the treatment of acute mania , but the relationship between serum levels and efficacy was not fully established .", "label": "", "metadata": {}, "score": "52.168205"}
{"text": "The figure above shows that there were more marijuana negative urines in adolescents while they were taking N - acetylcysteine , thank those taking placebo control .", "label": "", "metadata": {}, "score": "52.195805"}
{"text": "Tohen M , Sanger TM , McElroy SL , et al , for the Olanzapine HGEH Study Group .Olanzapine versus placebo in the treatment of acute mania .", "label": "", "metadata": {}, "score": "52.232353"}
{"text": "McElroy SL , Keck PE Jr , Stanton SP , et al .A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of psychotic mania .", "label": "", "metadata": {}, "score": "52.271675"}
{"text": "Lithium and divalproex were compared in a study by Bowden and colleagues . 8 In this 52-week trial , the time to discontinuation was significantly longer in the divalproex group compared with the lithium group .", "label": "", "metadata": {}, "score": "52.304016"}
{"text": "The trial measured the morphine - induced delay in gastrointestinal transit time using the lactulose hydrogen gastrointestinal motility test .NKTR-118 antagonized morphine - induced delay in gastrointestinal transit time , demonstrating the potential of the drug to relieve constipation .", "label": "", "metadata": {}, "score": "52.312996"}
{"text": "43 All studies were double - blind , randomized , and placebo - controlled .Study duration was typically 3 weeks , although the olanzapine trial lasted 6 weeks .", "label": "", "metadata": {}, "score": "52.429123"}
{"text": "10.1017/S1461145708009735 .PubMed .Brown EB , McElroy SL , Keck PE , Deldar A , Adams DH , Tohen M , Williamson DJ : A 7-week , randomized , double - blind trial of olanzapine / fluoxetine combination versus lamotrigine in the treatment of bipolar I depression .", "label": "", "metadata": {}, "score": "52.455082"}
{"text": "Proportion of Negative Urine Cannabinoid Tests Over Time Among Cannabis - Dependent Adolescents in a Randomized Controlled Trial of N - Acetylcysteine ( NAC)a 0 Baseline 1 10 20 30 40 50 60 2345678 Follow - up Study Week Percentage of Negative Urine Cannabinoid Tests .", "label": "", "metadata": {}, "score": "52.492493"}
{"text": "Interventions Medication .The university investigational drug service oversaw randomization , encased medications in identi- cal - appearing capsules , and dispensed them in weekly blister packs with specific instructions on when to take each dose .", "label": "", "metadata": {}, "score": "52.59581"}
{"text": "Additionally , a preplanned logistic regression model was used to analyze the odds of a negative cannabinoid test at the posttreatment follow - up .Exploratory analyses of selected secondary efficacy measures were conducted .", "label": "", "metadata": {}, "score": "52.65125"}
{"text": "Br J Psychiatry .10.1192/bjp.182.2.141 .PubMed .Juruena MF , Ottoni GL , Machado - Vieira R , Carneiro RM , Weingarthner N , Marquardt AR , Fleig SS , Broilo L , Busnello EA : Bipolar I and II disorder residual symptoms : oxcarbazepine and carbamazepine as add - on treatment to lithium in a double - blind , randomized trial .", "label": "", "metadata": {}, "score": "52.74353"}
{"text": "However , the combination of mood stabilizers and atypical antipsychotics has demonstrated significant improvements compared with monotherapy .In addition , the dosing and titration of medications can have a significant impact on both the speed and degree of clinical response .", "label": "", "metadata": {}, "score": "52.822407"}
{"text": "10.1016/j.jad.2008.06.001 .PubMed .Suppes T , Vieta E , Liu S , Brecher M , Paulsson B : Maintenance treatment for patients with bipolar I disorder : results from a north american study of quetiapine in combination with lithium or divalproex ( trial 127 ) .", "label": "", "metadata": {}, "score": "52.925323"}
{"text": "Sachs G , Sanchez R , Marcus R , et al .Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder : a 3-week placebo - controlled study .", "label": "", "metadata": {}, "score": "52.944794"}
{"text": "In contrast , Beasley and colleagues 57 noted greater weight gain associated with increasing olanzapine doses .Many common adverse effects can be mitigated through medication selection and dosing strategies .", "label": "", "metadata": {}, "score": "52.947815"}
{"text": "PubMed .Weisler RH , Keck PE , Swann AC , Cutler AJ , Ketter TA , Kalali AH : Extended - release carbamazepine capsules as monotherapy for acute mania in bipolar disorder : a multicenter , randomized , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "52.950577"}
{"text": "Key secondary end points of the study , time to first rescue free bowel movements ( RFBM ) after the first injection and the average increase in weekly number of RFBMs from baseline , were both statistically significant relative to placebo .", "label": "", "metadata": {}, "score": "52.983406"}
{"text": "PubMed .Amsterdam JD , Shults J : Comparison of fluoxetine , olanzapine , and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression -- lack of manic induction .", "label": "", "metadata": {}, "score": "53.00797"}
{"text": "One included 175 patients with a recent manic or hypomanic episode , 44 another included 463 patients with a recent episode of bipolar depression , 45 and the third included 372 patients in symptomatic remission from a manic episode .", "label": "", "metadata": {}, "score": "53.00954"}
{"text": "One study failed to find DHEA at a dose of 50 mg per day helpful for fibromyalgia .A 2006 review of acupuncture for fibromyalgia found five controlled studies , none of which were of high quality .", "label": "", "metadata": {}, "score": "53.282272"}
{"text": "( Substance abuse disorders are not exclusionary ) .The subject experiences any of the following within 4 hours after administration of oxycodone 30 mg during the blinded qualifying dosing period : adverse events requiring narcotic antagonist administration , emesis , or opioid toxicity ( see Section 10.0 ) .", "label": "", "metadata": {}, "score": "53.294754"}
{"text": "Treatment of fibromyalgia with acupuncture : a randomized , placebo controlled trial of 16 weeks duration .American College of Rheumatology Annual Meeting .Nov 2001 .", "label": "", "metadata": {}, "score": "53.326374"}
{"text": "To be considered a responder , the first three endpoints had to be met for at least nine of the 12 weeks of the treatment , while the fourth had to be met for at least six of the 12 weeks .", "label": "", "metadata": {}, "score": "53.332527"}
{"text": "Divalproex .The study by Bowden and colleagues 8 that compared divalproex , lithium , and placebo is the only double - blind , randomized , placebo - controlled trial to analyze the efficacy of divalproex in delaying the onset of a mood episode in bipolar I disorder .", "label": "", "metadata": {}, "score": "53.473343"}
{"text": "Patients with suicidal ideation or a history of suicide attempts may preferentially benefit from lithium maintenance therapy .Given the often significant side effects associated with psychopharmacologic treatment , it is important that clinicians encourage behavioral modifications that can mitigate adverse effects such as weight gain .", "label": "", "metadata": {}, "score": "53.524185"}
{"text": "Antidepressants have been shown to help chronic pain from many causes 2 and have been found to be effective in reducing fibromyalgia symptoms , even when given in doses too low to treat depression .", "label": "", "metadata": {}, "score": "53.581947"}
{"text": "However , data against acute bipolar depression and concerning maintenance are not homogenous .Olanzapine has proven efficacy against acute mania [ 51 - 55 ] .", "label": "", "metadata": {}, "score": "53.622986"}
{"text": "It is interesting to note that the higher dose of lorazepam was allowed in the trial with a lower starting olanzapine dosage of 10 mg / d .", "label": "", "metadata": {}, "score": "53.639526"}
{"text": "Although comparisons between SGA combination therapy and SGA monotherapy trials are often unreliable given different study designs , patient populations , and in the case of olanzapine , different study lengths , the response rates suggest that lower antipsychotic doses can be used in polytherapy treatment with good results .", "label": "", "metadata": {}, "score": "53.73397"}
{"text": "Data from the intent - to - treat analysis show that the median patient taking XR - NTX had 90 % opioid - free urine screens during the evaluation phase of the study .", "label": "", "metadata": {}, "score": "53.778366"}
{"text": "The two highest doses of TD-1211 demonstrated a statistically significant increase in average SBMs per week of 3.2 SBMs per week and 4.9 SBMs per week , respectively .", "label": "", "metadata": {}, "score": "53.792755"}
{"text": "Am J Psychiatry .PubMed .Weisler RH , Kalali AH , Ketter TA : A multicenter , randomized , double - blind , placebo - controlled trial of extended - release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes .", "label": "", "metadata": {}, "score": "53.795727"}
{"text": "At the posttreatment follow - up visit , 19.0 % ( 11/58 ) of the urine cannabinoid tests in the NAC group were negative , compared with 10.3 % ( 6/58 ) in the placebo group .", "label": "", "metadata": {}, "score": "53.989822"}
{"text": "Yatham LN , Paulsson B , Mullen J , Vagero AM .Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania .", "label": "", "metadata": {}, "score": "54.057945"}
{"text": "Treatment was well tolerated with adverse events mild to moderate in nature .The clinical response rate , measured using the Overall Subject Global Assessment ( OSGA ) , reached statistical significance versus placebo .", "label": "", "metadata": {}, "score": "54.08678"}
{"text": "The first double - blind dose of study drug will be administered at least 24 hours after the last dose of the two day qualifying period .", "label": "", "metadata": {}, "score": "54.12957"}
{"text": "Consumption of grapefruit or grapefruit products from at least 2 weeks prior to study drug administration until study conclusion .Ongoing treatment with medications that are primarily metabolized by CYP3A4 and may have increased plasma concentrations when co - administered with aprepitant , such as pimozide , terfenadine , astemizole or cisapride or corticosteroids , as well as benzodiazepines including midazolam , alprazolam , and triazolam .", "label": "", "metadata": {}, "score": "54.130333"}
{"text": "Active comparator trials .Active comparator trials for bipolar maintenance have evaluated lithium versus olanzapine , lithium versus divalproex , lithium versus lamotrigine , and olanzapine versus divalproex .", "label": "", "metadata": {}, "score": "54.165195"}
{"text": "YMRS reduction and clinical response .Olanzapine , risperidone , and quetiapine , in combination with valproate / divalproex or lithium , resulted in statistically significant reductions in YMRS scores and response rates compared with valproate / divalproex or lithium plus a placebo .", "label": "", "metadata": {}, "score": "54.54542"}
{"text": "Monotherapy versus placebo .In studies of individual medications versus placebo , 9 agents have shown efficacy and received an FDA indication for the treatment of acute mania .", "label": "", "metadata": {}, "score": "54.713394"}
{"text": "Fluoxetine was reported to be effective during the maintenance phase for bipolar II patients [ 100 , 101 , 106 ] .The data concerning combination and add - on treatment suggest that in acutely manic patients who are partial responders to lithium , valproate or carbamazepine , a good strategy would be to add haloperidol , risperidone , olanzapine , quetiapine or aripiprazole .", "label": "", "metadata": {}, "score": "54.717087"}
{"text": "Olanzapine versus placebo and haloperidol : acute phase results of the North American double - blind olanzapine trial .Neuropsychopharmacology .Ertugrul A , Meltzer HY .", "label": "", "metadata": {}, "score": "54.73252"}
{"text": "Although YMRS score changes did not differ from those seen with monotherapy , response rates were significantly higher with combination therapy .In a post hoc analysis , the authors excluded patients in the carbamazepine polytherapy group after discovering that carbamazepine reduced risperidone concentrations by 40 % .", "label": "", "metadata": {}, "score": "54.803307"}
{"text": "Bowden CL , Calabrese JR , Sachs G , et al .A placebo - controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "54.81974"}
{"text": "This long term data were included in the NDA filing currently under review by the FDA .July 2 , 2007 .Theravance announced positive results from a phase II trial of TD-5108 for the treatment of chronic constipation .", "label": "", "metadata": {}, "score": "54.920258"}
{"text": "10.1176/appi.ajp.162.7.1351 .PubMed .J Clin Psychiatry .10.4088/JCP.08m04942gre .PubMed .Young AH , McElroy SL , Bauer M , Philips N , Chang W , Olausson B , Paulsson B , Brecher M : A double - blind , placebo - controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression ( EMBOLDEN I ) .", "label": "", "metadata": {}, "score": "54.959885"}
{"text": "A mixture of malic acid and magnesium has been widely marketed as a treatment for fibromyalgia .However , in a double - blind study of 24 people , this treatment proved no more effective than placebo .", "label": "", "metadata": {}, "score": "55.044685"}
{"text": "Combination therapy .One double - blind , randomized , controlled trial to date has analyzed the combination of an antipsychotic and a mood stabilizer in bipolar maintenance treatment .", "label": "", "metadata": {}, "score": "55.10386"}
{"text": "The second phase II , open - label SYN-010 clinical trial was conducted for eight weeks at multiple centers in the U.S.The primary endpoint of this extension study was to evaluate the sustainability of the effect of one daily dose strength ( 42 mg ) of SYN-010 on breath methane production in breath methane - positive patients with IBS - C. Secondary endpoints included evaluation of the reduction in abdominal pain and bloating , the improvement in stool frequency and overall quality of life .", "label": "", "metadata": {}, "score": "55.24054"}
{"text": "Arch Gen Psychiatry .PubMed .Prien RF , Klett CJ , Caffey EM : Lithium carbonate and imipramine in prevention of affective episodes .A comparison in recurrent affective illness .", "label": "", "metadata": {}, "score": "55.311794"}
{"text": "TABLE 1 Treatment of mania with second - generation antipsychotics .All 5 SGAs ( olanzapine , risperidone , quetiapine , ziprasidone , and aripiprazole ) have been examined in at least 2 placebo - controlled , double - blind trials for the treatment of acute mania .", "label": "", "metadata": {}, "score": "55.328712"}
{"text": "Risperidone trials used day 3 as their first measurement date .Both studies gave an initial dosage of 3 mg / d .One study showed a separation from placebo on day 3 , 17 while another showed a separation on day 7 . 18 Quetiapine trials used a titration schedule to minimize adverse effects .", "label": "", "metadata": {}, "score": "55.329018"}
{"text": "These changes were correlated with the intensity of relapse , supported a causal link .Rats were trained to self - administer cocaine , then after two weeks of withdrawal relapse was induced by showing the rats a light / tone cue that had previously been shown only when cocaine was self - administered .", "label": "", "metadata": {}, "score": "55.33075"}
{"text": "A summary of the efficacy of various agents against the different phases of bipolar illness is shown in Table 1 . Discussion .In the current study , from the 16 ' agent class'/ ' treatment issue ' cases , only 3 possible class effects were detected .", "label": "", "metadata": {}, "score": "55.35346"}
{"text": "Preclinical findings suggest that the over - the - counter supplement N - acetylcysteine ( NAC ) , via glutamate modulation in the nucleus accumbens , holds promise as a pharmacotherapy for substance dependence .", "label": "", "metadata": {}, "score": "55.390965"}
{"text": "10.1192/bjp.bp.107.041301 .PubMed .Yatham LN , Grossman F , Augustyns I , Vieta E , Ravindran A : Mood stabilisers plus risperidone or placebo in the treatment of acute mania .", "label": "", "metadata": {}, "score": "55.43649"}
{"text": "When a similar analysis was performed for lithium , no serum level range differed from placebo .However , this result may have been influenced by insufficient power since the lithium group was half the size of the divalproex group .", "label": "", "metadata": {}, "score": "55.474068"}
{"text": "Safety data indicated that the drug was generally well tolerated .February 23 , 2004 .Sucampo reported positive results from a phase III trial investigating SPI-0211 , a chloride channel activator for the treatment of constipation .", "label": "", "metadata": {}, "score": "55.5438"}
{"text": "J Int Med Res .McCarty DJ , Csuka M , McCarthy , et al .Treatment of pain due to fibromyalgia with topical capsaicin : A pilot study .", "label": "", "metadata": {}, "score": "55.56907"}
{"text": "Statistical significance over placebo was also observed for several secondary endpoints , including change in SBM after week two , mean weekly SBM , percentage of subjects having first SBM within 24 and 48 hours and several symptoms of Chronic Idiopathic Constipation .", "label": "", "metadata": {}, "score": "55.748795"}
{"text": "Placebo - controlled trials of SGAs showed similar changes in YMRS scores and response rates , but the best way to establish relative efficacy is to conduct a head - to - head comparator trial .", "label": "", "metadata": {}, "score": "55.763695"}
{"text": "By definition , antidepressants are not used against acute mania ( and there are no trials during the acute manic phase ) .From RCTs against acute bipolar depression , older studies suggested that amitriptiline [ 95 ] and maybe imipramine could be effective [ 96 - 98 ] , with data being somewhat stronger for fluoxetine ( particularly in bipolar II patients ) [ 99 - 102 ] .", "label": "", "metadata": {}, "score": "55.907307"}
{"text": "For the secondary endpoint : while the proportion of responders was higher in the 0.25 mg treatment group ( 42.5 % vs. 29.3 % in placebo ) , statistical significance was not achieved .", "label": "", "metadata": {}, "score": "55.949745"}
{"text": "Based on these results , Dynogen plans to initiate a phase IIb trial later in 2007 .February 20 , 2006 .Progenics issued positive results of a phase III trial of methylnaltrexone for the treatment of opioid induced constipation .", "label": "", "metadata": {}, "score": "55.9633"}
{"text": "Neuropsychological testing will occur at Weeks 0 and 4 and 8 .Specific Aim 1 : To evaluate the relative efficacy of aprepitant 125 mg / d vs. placebo for reducing cannabis withdrawal symptoms in cannabis dependent outpatients , including anxiety , mood , craving and sleep symptoms .", "label": "", "metadata": {}, "score": "55.96482"}
{"text": "Both medications were associated with unfavorable side effects .Lithium resulted in greater polyuria and thirst , while divalproex was associated with more sedation , infection , and tinnitus .", "label": "", "metadata": {}, "score": "55.975956"}
{"text": "The pharmacokinetics of NKTR-118 were dose - proportional and the observed terminal half - life of the drug was approximately eleven hours , independent of dose .", "label": "", "metadata": {}, "score": "55.981476"}
{"text": "Patients who predominantly experience depressive episodes would probably benefit from treatment with lamotrigine or olanzapine , while all 4 maintenance agents have shown efficacy in delaying the time to a manic episode .", "label": "", "metadata": {}, "score": "56.031704"}
{"text": "Calabrese JR , Bowden CL , Sachs GS , et al , for the Lamictal 602 Study Group .A double - blind , placebo - controlled study of lamotrigine monotherapy in outpatients with bipolar I depression .", "label": "", "metadata": {}, "score": "56.03784"}
{"text": "10.1016/j.jad.2009.12.028 .PubMed .McIntyre RS , Cohen M , Zhao J , Alphs L , Macek TA , Panagides J : A 3-week , randomized , placebo - controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states .", "label": "", "metadata": {}, "score": "56.043373"}
{"text": "Lamotrigine .Two randomized controlled trials compared lamotrigine with placebo .44,45 Dosing of lamotrigine ranged from 50 to 400 mg .Patients recovering from manic episodes had a 5 % study completion rate , compared with 0 % in the placebo group .", "label": "", "metadata": {}, "score": "56.076317"}
{"text": "The subject has a positive response to oxycodone in the blinded qualifying period as defined by a VAS Liking score for oxycodone that is at least 20 points greater than that for placebo .", "label": "", "metadata": {}, "score": "56.18486"}
{"text": "Both the 25 and 50 mg dose cohorts reached the endpoints with statistical significance .There was also a statistically significant difference in median time to first SBM for subjects the 25 mg and 50 mg dose cohorts as compared to placebo .", "label": "", "metadata": {}, "score": "56.228394"}
{"text": "Study 303 enrolled 643 subjects .Study 01 enrolled 633 subjects .November 2 , 2009 .Nektar issued positive results from a phase II trial of NKTR-118 for the treatment of opioid induced constipation .", "label": "", "metadata": {}, "score": "56.242836"}
{"text": "April 11 , 2005 .Alkermes reported positive results of a phase III trial of Vivitrex ( naltrexone long - acting injection ) , for the treatment of alcohol dependence .", "label": "", "metadata": {}, "score": "56.687874"}
{"text": "Risperidone polytherapy was associated with increased EPS in 1 of 2 studies and greater weight gain in both studies ( averaging 2.05 kg ) .Quetiapine polytherapy was associated with more somnolence , dry mouth , asthenia , postural hypotension , and a weight gain of 1.97 kg compared with 0.27 kg in monotherapy .", "label": "", "metadata": {}, "score": "56.74955"}
{"text": "Ziprasidone studies evaluated changes based on Mania Rating Scale scores of the Schedule for Affective Disorders and Schizophrenia ( MRS - SADS ) .Most studies lasted 3 weeks , with the exception of olanzapine ( 4 weeks ) and quetiapine ( 12 weeks ) .", "label": "", "metadata": {}, "score": "56.858727"}
{"text": "Hirschfeld RM , Allen MH , McEvoy JP , et al .Safety and tolerability of oral loading valproate in acutely manic bipolar patients .J Clin Psychiatry .", "label": "", "metadata": {}, "score": "56.880936"}
{"text": "In comparison , monotherapy was associated with an average YMRS score reduction of 9.8 and a clinical response of 39 % ( Figure ) .One study analyzing combination therapy failed to separate from monotherapy at the primary end point of YMRS score reduction .", "label": "", "metadata": {}, "score": "56.973892"}
{"text": "that?the?over - the - counter ?supplement?N- acetylcysteine ?( NAC ) , ? via?glutamate?mod- ulation?in?the?nucleus?accumbens , ? holds ?promise?as?a?pharmacotherapy?for?sub- stance?dependence .The?authors?investi- gated?NAC?as?a?novel?cannabis?cessation ? treatment ? in ? adolescents , ? a ? vulnerable ?", "label": "", "metadata": {}, "score": "57.022408"}
{"text": "( ages ?years ; ? received ?NAC ? mg ) ?or?placebo?twice?daily?as ?well?as?a?contingency?management?inter- vention ? and ? brief ? minutes ) ? weekly ?", "label": "", "metadata": {}, "score": "57.064774"}
{"text": "Missing urine samples were as- sumed positive for cannabinoids .At the posttreatment follow - up visit , 19 % of the urine tests in the N - acetylcysteine group were negative , compared to 10 % in the placebo group .", "label": "", "metadata": {}, "score": "57.081543"}
{"text": "Pain Therapeutics reported results from a study of Remoxy , an oral abuse resistant formulation of oxycodone .The double blind , placebo and active - controlled , six - way crossover study enrolled 45 healthy subjects with histories of non - dependent recreational opioid use .", "label": "", "metadata": {}, "score": "57.081963"}
{"text": "yic.0000171519.64080 .c9 .PubMed .Garfinkel PE , Stancer HC , Persad E : A comparison of haloperidol , lithium carbonate and their combination in the treatment of mania .", "label": "", "metadata": {}, "score": "57.122646"}
{"text": "Valproate was more effective than lithium when added on antidepressants for the prevention of bipolar depression [ 133 ] .A 40-week placebo controlled study of the safety and efficacy of asenapine when added to lithium or valproate ( NCT00145509 ) and a 40-week extension study of asenapine vs olanzapine ( Ares 7501007 ) have also been conducted .", "label": "", "metadata": {}, "score": "57.25792"}
{"text": "Double - blind , placebo - controlled cross - over study of intravenous S - adenosyl - L - methionine in patients with fibromyalgia .Scand J Rheumatol .", "label": "", "metadata": {}, "score": "57.308105"}
{"text": "There were two opioid withdrawal AEs reported in patients taking naloxegol ( both were deemed unrelated to treatment with naloxegol ) .January 14 , 2013 .", "label": "", "metadata": {}, "score": "57.312614"}
{"text": "Side effects in combination therapy were generally greater than those with mood stabilizer monotherapy .Study discontinuations because of adverse events occurred more frequently with olanzapine polytherapy , while no statistical difference was seen in other studies .", "label": "", "metadata": {}, "score": "57.314873"}
{"text": "The primary aim of this clinical trial is to evaluate the efficacy and safety of a novel neurokinin1 ( NK1 ) receptor antagonist , aprepitant ( Emend ) , ( 125mg / day ) , in outpatients with current cannabis dependence .", "label": "", "metadata": {}, "score": "57.346306"}
{"text": "The primary goal of ESENSE 1 and ESENSE 2 was to evaluate the efficacy of as - needed use of Selincro versus placebo in reducing the number of heavy drinking days ( HDD ) and the monthly total alcohol consumption ( TAC ) over a period of six months .", "label": "", "metadata": {}, "score": "57.357815"}
{"text": "The quetiapine study by Bowden and colleagues 19 that employed concomitant use of lorazepam , chloral hydrate , and zolpidem reported the highest rates of completion .", "label": "", "metadata": {}, "score": "57.368015"}
{"text": "Aripiprazole .The second atypical antipsychotic trial looking at bipolar relapse prevention compared aripiprazole with placebo .53 In this double - blind study , 161 patients with manic or mixed episodes who met the criteria for stabilization after open - label treatment with aripiprazole were randomized to a 26-week maintenance phase .", "label": "", "metadata": {}, "score": "57.381966"}
{"text": "WEX Pharmaceuticals has announced results of a phase IIa trial of Tetrodin ( tetrodotoxin ) , for the treatment of withdrawal symptoms associated with opioid dependence .", "label": "", "metadata": {}, "score": "57.393456"}
{"text": "Olanzapine versus divalproex in the treatment of acute mania .Am J Psychiatry .Zajecka JM , Weisler R , Sachs G , et al .", "label": "", "metadata": {}, "score": "57.433968"}
{"text": "PubMed .Cohn JB , Collins G , Ashbrook E , Wernicke JF : A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder .", "label": "", "metadata": {}, "score": "57.449516"}
{"text": "10.1111/j.1399 -5618.2007.00491.x .PubMed .Bowden CL , Grunze H , Mullen J , Brecher M , Paulsson B , Jones M , Vagero M , Svensson K : A randomized , double - blind , placebo - controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder .", "label": "", "metadata": {}, "score": "57.46902"}
{"text": "It was not until the last decade that comparisons between lithium and placebo occurred using modern methodology , often in studies analyzing newer medications needing an active comparator arm .", "label": "", "metadata": {}, "score": "57.58963"}
{"text": "Based on the results , Nektar plans to development into phase III trials .October 27 , 2008 .Movetis reported positive results from two clinical trials of prucalopride for the treatment of constipation .", "label": "", "metadata": {}, "score": "57.71048"}
{"text": "Notable in the bipolar maintenance trials was a tendency for patients to gain weight early in treatment .The preponderance of weight gain occurred during short - duration open - label phases , with markedly less weight gain seen in the longer maintenance phases .", "label": "", "metadata": {}, "score": "57.731224"}
{"text": "The mean discontinuation rate for adverse events across all groups was 3 % , suggesting similar tolerability .Taken together , the data suggest that a valproate / divalproex serum concentration of 94.1 \u00b5g / mL or higher provides optimal efficacy without increased side effects .", "label": "", "metadata": {}, "score": "57.79471"}
{"text": "There were 78 ( 87.6 % ) responders in the sublingual buprenorphine / naloxone arm and 81 ( 96.4 % ) responders in the Probuphine arm .", "label": "", "metadata": {}, "score": "57.818855"}
{"text": "Urine tests were assumed to be positive for all missed visits .The odds ratio is adjusted for baseline urine cannabinoid test results , years of reported cannabis use , and major depressive disorder .", "label": "", "metadata": {}, "score": "57.910637"}
{"text": "The oral - loaded group showed a statistically significant improvement relative to the standard - titration group at days 5 , 7/8 , and 10 in the MRS , Manic Syndrome Scale , and Behavior and Ideation Scale .", "label": "", "metadata": {}, "score": "58.0655"}
{"text": "10.4088/JCP.v66n0809 .PubMed .Hirschfeld RM , Keck PE , Kramer M , Karcher K , Canuso C , Eerdekens M , Grossman F : Rapid antimanic effect of risperidone monotherapy : a 3-week multicenter , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "58.124794"}
{"text": "May 18 , 2009 .Progenics released positive results from a phase III trial of Relistor ( methylnaltrexone ) for the treatment of opioid - induced constipation in patients with chronic , non - cancer pain .", "label": "", "metadata": {}, "score": "58.138943"}
{"text": "The most common side effects were flatulence and transient abdominal cramping .The randomized , double blind study enrolled 33 subjects with advanced medical illness who were experiencing opioid - induced constipation .", "label": "", "metadata": {}, "score": "58.203133"}
{"text": "From the 16 ' agent class'/ ' treatment issue ' cases , only 3 possible class effects were detected , and they all concerned acute mania and antipsychotics .", "label": "", "metadata": {}, "score": "58.20456"}
{"text": "The rate of relapse was 47 % in the olanzapine - group compared with 80 % in the placebo group .Time to a manic episode and time to a depressive episode were also significantly delayed with olanzapine .", "label": "", "metadata": {}, "score": "58.245026"}
{"text": "jcp.0000248603.76231 .b7 .PubMed .Suppes T , Datto C , Minkwitz M , Nordenhem A , Walker C , Darko D : Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression .", "label": "", "metadata": {}, "score": "58.32379"}
{"text": "Top - line data indicate that the 72mcg dose of linaclotide demonstrated statistically significant improvement compared to placebo on the 12-week complete spontaneous bowel movements ( CSBM ) overall responder endpoint , the primary endpoint for the trial .", "label": "", "metadata": {}, "score": "58.327423"}
{"text": "Specific Aim 3 : To evaluate the relative efficacy of aprepitant 125 mg / d vs. placebo for reducing cannabis related impairments in executive functioning in cannabis dependent outpatients .", "label": "", "metadata": {}, "score": "58.33351"}
{"text": "10.1176/appi.ajp.157.8.1351 .PubMed .Br J Psychiatry .10.1192/bjp.184.4.337 .PubMed .Neuropsychopharmacology .10.1038/sj.npp.1300190 .PubMed .Geddes JR , Goodwin GM , Rendell J , Azorin JM , Cipriani A , Ostacher MJ , Morriss R , Alder N , Juszczak E : Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder ( BALANCE ) : a randomised open - label trial .", "label": "", "metadata": {}, "score": "58.431404"}
{"text": "PubMed .Lenox RH , Newhouse PA , Creelman WL , Whitaker TM : Adjunctive treatment of manic agitation with lorazepam versus haloperidol : a double - blind study .", "label": "", "metadata": {}, "score": "58.468506"}
{"text": "Additional subgroup analyses found that both women and white subjects had a prolonged time to symptomatic relapse of any mood episode with combination therapy .Subjects treated with combination therapy had significantly greater weight gain ( 3.1 kg vs -1.8 kg ) .", "label": "", "metadata": {}, "score": "58.485687"}
{"text": "Without treatment , more than 90 % of patients will experience subsequent manic or depressive episodes .6 Even with treatment , relapse rates range from 40 % to 60 % .", "label": "", "metadata": {}, "score": "58.52593"}
{"text": "When you inject a medication , the effects can be quite different than when you take it orally .For that reason , these studies are of questionable relevance .", "label": "", "metadata": {}, "score": "58.540962"}
{"text": "Smoking cessation was confirmed by serum cotinine and carbon monoxide levels , and subjects received NicVAX treatments in the absence of any other pharmacological or behavioral therapies .", "label": "", "metadata": {}, "score": "58.59113"}
{"text": "PubMed .Sachs GS , Grossman F , Ghaemi SN , Okamoto A , Bowden CL : Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania : a double - blind , placebo - controlled comparison of efficacy and safety .", "label": "", "metadata": {}, "score": "58.612026"}
{"text": "In addition , secondary endpoints were not reached in either dose group and elevation in liver enzymes was observed in some of the nalmefene - treated subjects .", "label": "", "metadata": {}, "score": "58.678116"}
{"text": "10.4088/JCP.09m05482yel .PubMed .McIntyre RS , Cohen M , Zhao J , Alphs L , Macek TA , Panagides J : Asenapine in the treatment of acute mania in bipolar I disorder : a randomized , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "58.74883"}
{"text": "The design and results of these studies are summarized in Table 1 .Starting dose and onset of action .The primary goal in treating bipolar mania is to stabilize the patient as rapidly and safely as possible .", "label": "", "metadata": {}, "score": "58.80936"}
{"text": "J Clin Psychiatry .Baldessarini RJ , Tondo L , Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic - depressive disorders .", "label": "", "metadata": {}, "score": "58.843895"}
{"text": "10.4088/JCP.v65n0405 .PubMed .Weisler RH , Hirschfeld R , Cutler AJ , Gazda T , Ketter TA , Keck PE , Swann A , Kalali A : Extended - release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised , double - blind , placebo - controlled trials .", "label": "", "metadata": {}, "score": "58.92238"}
{"text": "Various forms of exercise , 4,5,43,53,54 especially aerobic exercise , have been shown to be helpful for symptoms associated with fibromyalgia , most notably global well - being and physical functioning .", "label": "", "metadata": {}, "score": "58.960915"}
{"text": "PubMed .Tohen M , Bowden CL , Smulevich AB , Bergstrom R , Quinlan T , Osuntokun O , Wang WV , Oliff HS , Martenyi F , Kryzhanovskaya LA , Greil W : Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes .", "label": "", "metadata": {}, "score": "59.243282"}
{"text": "39 Risperidone combination therapy resulted in a YMRS score reduction of 14.3 and a response rate of 53 % .40 Quetiapine , in the combined analysis of 2 polytherapy trials , was found to reduce YMRS scores by 15.3 and produce a 56 % response rate .", "label": "", "metadata": {}, "score": "59.25414"}
{"text": "Accessed November 21 , 2006 .Kwon SJ , Choi JS , Bahk WM , et al .Weight management program for treatment - emergent weight gain in olanzapine - treated patients with schizophrenia or schizoaffective disorder : a 12-week randomized controlled clinical trial .", "label": "", "metadata": {}, "score": "59.311478"}
{"text": "Alkermes reported positive results from a phase II trial of Vivitrex ( Medisorb naltrexone ) , an injectable sustained - release formulation of naltrexone .The multicenter , randomized , double - blind , placebo - controlled trial was conducted at five treatment centers in the United States and Europe .", "label": "", "metadata": {}, "score": "59.32636"}
{"text": "NKTR-118 was rapidly absorbed with dose - proportional pharmacokinetics and it was well tolerated at single doses up to 1,000 mg .Based on the results , Nektar plans to initiate a phase I multi - dose trial later in 2007 .", "label": "", "metadata": {}, "score": "59.32907"}
{"text": "10.1111/j.1399 -5618.2010.00815.x .PubMed .Glen AI , Johnson AL , Shepherd M : Continuation therapy with lithium and amitriptyline in unipolar depressive illness : a randomized , double - blind , controlled trial .", "label": "", "metadata": {}, "score": "59.337208"}
{"text": "Lower suicide risk with long - term lithium treatment in major affective illness : a meta - analysis .Acta Psychiatr Scand .Baldessarini RJ , Tondo L , Hennen J , Viguera AC .", "label": "", "metadata": {}, "score": "59.345234"}
{"text": "No data are available concerning bipolar depression or the maintenance phase .The data are also positive for paliperidone against acute mania ( one positive RCT with flexible dosage ( NCT00309699 ) [ 94 ] and one negative with fixed dosage ( NCT00299715 ) ) , but no data are available concerning bipolar depression or the maintenance phase .", "label": "", "metadata": {}, "score": "59.40007"}
{"text": "A study that purportedly found melatonin helpful was , in fact , too poorly designed to provide meaningful evidence .The effectiveness of IV - infused micronutrient therapy ( eg , Myers ' Cocktail ) is unclear .", "label": "", "metadata": {}, "score": "59.419846"}
{"text": "AJP?Audio , ? is?discussed?in?an?editorial?by?Dr .Bukstein ?( p. ?is?an?article?that?provides ?Clinical Guidance ?( p. ?and?is?the?subject?of?a?CMe?course ? ( p. ?Page 2 . TRiAl OF N - ACeTylCySTeiNe iN CANNABiS - DePeNDeNT ADOleSCeNTS 806 ?", "label": "", "metadata": {}, "score": "59.42675"}
{"text": "10.1176/appi.ajp.160.4.741 .PubMed .Potkin SG , Keck PE , Segal S , Ice K , English P : Ziprasidone in acute bipolar mania : a 21-day randomized , double - blind , placebo - controlled replication trial .", "label": "", "metadata": {}, "score": "59.434853"}
{"text": "The company plans to file its first NDA with plecanatide in the CIC indication in January 2016 .June 8 , 2015 .Ardelyx reported results of a phase IIb study of tenapanor for irritable bowel syndrome with constipation ( IBS - C ) .", "label": "", "metadata": {}, "score": "59.467163"}
{"text": "An intent - to - treat approach including all randomized participants was used .In all analyses , participants who were lost to follow - up or were absent from visits were coded as having a positive urine cannabinoid test at every missed visit .", "label": "", "metadata": {}, "score": "59.47522"}
{"text": "AstraZeneca released results of a phase III trial of naloxegol for the treatment of non - cancer pain and opioid - induced constipation ( OIC ) .", "label": "", "metadata": {}, "score": "59.82197"}
{"text": "Langhorst J , Klose P , Musial F , et al .Efficacy of acupuncture in fibromyalgia syndrome -- a systematic review with a meta - analysis of controlled clinical trials .", "label": "", "metadata": {}, "score": "59.823914"}
{"text": "2002;102:321 - 325 .Citera G , Arias MA , Maldonado - Cocco JA , et al .The effect of melatonin in patients with fibromyalgia : a pilot study .", "label": "", "metadata": {}, "score": "59.8323"}
{"text": "Analyses indicate response rates of 96.4 % for the Probuphine arm and 87.6 % for the sublingual buprenorphine / naloxone arm .The two - sided 95 % confidence interval ( 0.009 , 0.167 ) of the treatment difference ( Probuphine - sublingual buprenorphine / naloxone ) was well within the pre - defined successful margin for non - inferiority .", "label": "", "metadata": {}, "score": "59.930588"}
{"text": "10.1192/bjp.187.3.229 .PubMed .Quiroz JA , Yatham LN , Palumbo JM , Karcher K , Kushner S , Kusumakar V : Risperidone long - acting injectable monotherapy in the maintenance treatment of bipolar I disorder .", "label": "", "metadata": {}, "score": "59.943115"}
{"text": "10.4088/JCP.v68n1003 .PubMed .Gopal S , Steffens DC , Kramer ML , Olsen MK : Symptomatic remission in patients with bipolar mania : results from a double - blind , placebo - controlled trial of risperidone monotherapy .", "label": "", "metadata": {}, "score": "60.019447"}
{"text": "jcp.0000169068.34322.70 .PubMed .Stahl S , Lombardo I , Loebel A , Mandel FS : Efficacy of ziprasidone in dysphoric mania : pooled analysis of two double - blind studies .", "label": "", "metadata": {}, "score": "60.102184"}
{"text": "Find- ings?support?NAC?as?a?pharmacotherapy ? to ? complement ? psychosocial ? treatment ? for?cannabis?dependence?in?adolescents .Cannabis is the most commonly used illicit substance among adolescents , and rates of use are increasing .", "label": "", "metadata": {}, "score": "60.134842"}
{"text": "Page 3 .GRAy , CARPeNTeR , BAKeR , eT Al .Am J Psychiatry 169:8 , August 2012 ajp.psychiatryonline.org 807 bidities .Baseline demographic and clinical characteristics were independently tested for association with efficacy outcome , and those significantly associated were included as predictors in ad- justed models .", "label": "", "metadata": {}, "score": "60.176353"}
{"text": "The hazard ratio is adjusted for baseline urine cannabinoid test results and years of reported cannabis use .Means and mean differences are ad- justed for baseline urine cannabinoid test results , years of reported cannabis use , and self - reported percent of days used in the 30 days prior to study entry .", "label": "", "metadata": {}, "score": "60.19764"}
{"text": "Other Proposed Treatments for Fibromyalgia .The blue - green algae Chlorella pyrenoidosa might be helpful for fibromyalgia .In a double - blind , placebo - controlled trial , 37 people with fibromyalgia were given either placebo or chlorella supplements at a dose of 10 g daily .", "label": "", "metadata": {}, "score": "60.234932"}
{"text": "The treatment was generally well tolerated and the most common adverse event was diarrhea .November 1 , 2010 .Theravance released positive results from a phase II trial of TD-1211 for opioid - induced constipation .", "label": "", "metadata": {}, "score": "60.313267"}
{"text": "Psychopharmacology ( Berl ) .Goldberg JF , Garno JL , Leon AC , et al .Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients .", "label": "", "metadata": {}, "score": "60.338676"}
{"text": "PubMed .Pope HG , McElroy SL , Keck PE , Hudson JI : Valproate in the treatment of acute mania .A placebo - controlled study .", "label": "", "metadata": {}, "score": "60.349884"}
{"text": "We aim to evaluate the effect of paracetamol at the most widely used doses 2 and 3g / day on INR in stable patients treated with warfarin in a double blind randomized placebo - controlled trial and to identify the mechanism involved in this interaction in vivo .", "label": "", "metadata": {}, "score": "60.37191"}
{"text": "Adolescents are particularly prone to adverse consequences of cannabis use and progression to dependence ( 2 - 5 ) , but existing cessation treatments are associated with low abstinence rates ( 6 - 8 ) .", "label": "", "metadata": {}, "score": "60.466125"}
{"text": "Assefi NP , Sherman KJ , Jacobsen C , et al .A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia .Ann Intern Med .", "label": "", "metadata": {}, "score": "60.548935"}
{"text": "No HPLC peak area matrix effect was greater than 10 % .A human plasma sample from a prior analysis for S-(N , N - diethylcarbamoyl ) glutathione ( CARB ) was found to have DETC NAC as well .", "label": "", "metadata": {}, "score": "60.609863"}
{"text": "The subject is pregnant or breastfeeding .The subject has received an investigational drug within 30 days prior to initiation of this study .The subject exhibits signs / symptoms of opioid withdrawal during the 24-hour observation period after check - in .", "label": "", "metadata": {}, "score": "60.651398"}
{"text": "December 4 , 2006 .Pain Therapeutics reported positive results from a phase I trial of PTI-202 , an abuse- resistant opioid painkiller .The trial was designed to assess the safety , tolerability , pharmacokinetic and pharmacodynamic profiles of a single , oral dose of PTI-202 in healthy subjects .", "label": "", "metadata": {}, "score": "60.731323"}
{"text": "10.4088/JCP.v66n0116 .PubMed .McElroy SL , Martens BE , Winstanley EL , Creech R , Malhotra S , Keck PE : Placebo - controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate - to - severe hypomania or mild mania .", "label": "", "metadata": {}, "score": "60.802902"}
{"text": "10.1097/YIC.0b013e3280119dfb .PubMed .J Clin Psychiatry .10.4088/JCP.v69n0510 .PubMed .Endicott J , Rajagopalan K , Minkwitz M , Macfadden W : A randomized , double - blind , placebo - controlled study of quetiapine in the treatment of bipolar I and II depression : improvements in quality of life .", "label": "", "metadata": {}, "score": "60.863953"}
{"text": "Separation from placebo occurred on day 4 and day 7 .19,20 Ziprasidone studies used day 2 as the first measurement date .The starting dosage was 80 mg / d on day 1 , and 160 mg / d by day 2 .", "label": "", "metadata": {}, "score": "61.00351"}
{"text": "It may be that NAC and contingency man- agement exert synergistic treatment effects , a possibility that can be investigated in a 2\u00d72 trial ( NAC versus placebo and contingency management versus noncontingency management ) to detect interaction effects ( 40 ) . Alterna- tively , it may be that NAC requires a nonspecific but pow- erful psychosocial treatment platform to exert its effects .", "label": "", "metadata": {}, "score": "61.018013"}
{"text": "Page 5 .GRAy , CARPeNTeR , BAKeR , eT Al .Am J Psychiatry 169:8 , August 2012 ajp.psychiatryonline.org 809 Safety and Tolerability Interim monitoring of adverse events was conducted every 6 months by an independent data and safety moni- toring board .", "label": "", "metadata": {}, "score": "61.018257"}
{"text": "J Clin Psychiatry .10.4088/JCP.09m05026gre .PubMed .Amsterdam JD , Shults J : Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression : a double - blind , placebo - substitution , continuation study .", "label": "", "metadata": {}, "score": "61.039257"}
{"text": "Results were reported at the 2004 Annual Meeting of the International Society of Addiction Medicine in Helsinki .June 24 , 2002 .Purdue Pharma L.P. reported that additional studies would be required to more fully assess the safety and effectiveness of the company 's oxycodone / naloxone product , which was developed to reduce abuse of OxyContin ( oxycodone HCl ) .", "label": "", "metadata": {}, "score": "61.093616"}
{"text": "Response to treatment is typically defined as a 50 % or greater reduction on the primary efficacy measure ( YMRS or MRS ) or \" much or very much improvement \" on the Clinical Global Impression Improvement ( CGI - I ) scale .", "label": "", "metadata": {}, "score": "61.123817"}
{"text": "It appears that the neurobiological and behavioral effects of NAC may not be specific to a particular substance , suggest- ing that NAC may be a promising candidate medication for treatment of other substance use disorders , whether by modulation of glutamate or by other mechanisms .", "label": "", "metadata": {}, "score": "61.137592"}
{"text": "Official Title : .A Single - Center , Randomized , Double - Blind , Active- and Placebo - Controlled Crossover Study to Evaluate the Subjective Effects of PTI-801 in Non - Physically Dependent Subjects With a History of Drug Abuse .", "label": "", "metadata": {}, "score": "61.196533"}
{"text": "31 Within the atypical antipsychotic class , risperidone is associated with the highest risk of EPS .58 This risk can be minimized by limiting the daily dose to 6 mg or less .", "label": "", "metadata": {}, "score": "61.207764"}
{"text": "Polytherapy .Polytherapy is commonly used in the treatment of initial and refractory episodes of mania .This generally involves the combination of a mood stabilizer with an SGA .", "label": "", "metadata": {}, "score": "61.22073"}
{"text": "Both the discontinuation rate for mania or depression and the time in maintenance treatment before discontinuation for any reason were superior in the divalproex medium - therapeutic range compared with placebo .", "label": "", "metadata": {}, "score": "61.2247"}
{"text": "However the recently published BALANCE study could neither reliably confirm nor refute a benefit of combination therapy compared with lithium monotherapy [ 134 ] at least partially because of methodological flaws [ 135 ] .", "label": "", "metadata": {}, "score": "61.250427"}
{"text": "10.1097/jcp.0b013e3181618eb4 .PubMed .Keck PE , Calabrese JR , McQuade RD , Carson WH , Carlson BX , Rollin LM , Marcus RN , Sanchez R : A randomized , double - blind , placebo - controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "61.311623"}
{"text": "Approximately 14 subjects will be randomized to one of fourteen sequences selected from a balanced 7x7 Latin square design and its mirror image .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Crossover Assignment Masking : Double Blind ( Subject , Caregiver , Investigator )", "label": "", "metadata": {}, "score": "61.31858"}
{"text": "10.1016/j.biopsych.2010.01.015 .PubMed .Keck PE , Versiani M , Potkin S , West SA , Giller E , Ice K : Ziprasidone in the treatment of acute bipolar mania : a three - week , placebo - controlled , double - blind , randomized trial .", "label": "", "metadata": {}, "score": "61.36503"}
{"text": "Secondary endpoints were also reached ; there was no reversal of analgesia as measured by a change in pain Numerical Rating Scale and no increase in opiate use .", "label": "", "metadata": {}, "score": "61.41558"}
{"text": "J Clin Psychopharmacol .PubMed .Weisler R , Dunn J , English P : Adjunctive Ziprasidone for acute bipolar mania : randomized , placebo - controlled trial .", "label": "", "metadata": {}, "score": "61.584457"}
{"text": "10.4088/JCP.08m04995gre .PubMed .Thase ME , Macfadden W , Weisler RH , Chang W , Paulsson B , Khan A , Calabrese JR : Efficacy of quetiapine monotherapy in bipolar I and II depression : a double - blind , placebo - controlled study ( the BOLDER II study ) .", "label": "", "metadata": {}, "score": "61.619514"}
{"text": "11 However , polytherapy is also associated with significantly higher rates of adverse effects .Four studies analyzing combination therapy for the treatment of mania in adults have been published .", "label": "", "metadata": {}, "score": "61.664413"}
{"text": "10.1016/j.jad.2004.09.009 .PubMed .J Clin Psychiatry .10.4088/JCP.v68n1203 .PubMed .Bond DJ , Lam RW , Yatham LN : Divalproex sodium versus placebo in the treatment of acute bipolar depression : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "61.687622"}
{"text": "Differences between groups for these hypotheses on multiple related outcome mea- sures would support the treatment effect of NAC on cannabis use .Thus , we specified , a priori , the primary outcome as well as sec- ondary comparisons and did not adjust for multiple comparisons of groups on these outcomes ( 35 - 37 ) .", "label": "", "metadata": {}, "score": "61.815792"}
{"text": "Khanna S , Vieta E , Lyons B , et al .Risperidone in the treatment of acute mania : double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "61.822273"}
{"text": "TD-1211 was generally well tolerated .October 18 , 2010 .Albireo released positive results from a phase IIb trial of A3309 for the treatment of chronic idiopathic constipation ( CIC ) .", "label": "", "metadata": {}, "score": "61.82988"}
{"text": "Table 1 .Monotherapy data on the efficacy of agents and classes of agents in different phases of bipolar illness .Methods .We reviewed the available treatment data from randomized controlled trials ( RCTs ) .", "label": "", "metadata": {}, "score": "61.837227"}
{"text": "As a result , side effect mitigation has become an important part of the treatment plan .This article examines the latest research on treating acute manic episodes and reducing the risk of future episodes , including optimal dosing and titration schedules .", "label": "", "metadata": {}, "score": "61.86019"}
{"text": "10.1016/j.jad.2009.06.023 .PubMed .Bowden CL , Vieta E , Ice KS , Schwartz JH , Wang PP , Versavel M : Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder : a 6-month , randomized , placebo - controlled , double - blind trial .", "label": "", "metadata": {}, "score": "61.87549"}
{"text": "21,22 Aripiprazole studies both started at a dosage of 30 mg / d and could be decreased to 15 mg / d on day 2 to minimize adverse effects .", "label": "", "metadata": {}, "score": "61.898247"}
{"text": "10.1176/appi.ajp.2008.07101560 .PubMed .Muller - Oerlinghausen B , Retzow A , Henn FA , Giedke H , Walden J : Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania : a prospective , randomized , double - blind , placebo - controlled , multicenter study .", "label": "", "metadata": {}, "score": "62.20236"}
{"text": "Hargrove JB , Bennett RM , Simons DG , et al .A randomized placebo - controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients .", "label": "", "metadata": {}, "score": "62.20652"}
{"text": "Relapse induced by cues predicting cocaine depends on rapid , transient synaptic potentiation .Neuron , in press , 2013 .Drs .Gipson and Kupchik are postdoctoral fellows in the lab of Dr. Kalivas , and Dr. Shen is an Assistant Professor at Peking University in Beijing .", "label": "", "metadata": {}, "score": "62.260143"}
{"text": "25 The average placebo - corrected response rate in all SGA studies ranged from 16 % to 23 % ( olanzapine 23 % , risperidone 23 % , quetiapine 17 % , ziprasidone 16 % , and aripiprazole 21 % ) .", "label": "", "metadata": {}, "score": "62.385353"}
{"text": "Int J Neuropsychopharmacol .Bowden CL , Asnia GM , Ginsberg LD , et al .Safety and tolerability of lamotrigine for bipolar disorder .Drug Saf .", "label": "", "metadata": {}, "score": "62.400078"}
{"text": "Use of drugs ( e.g. , rifampin , carbamazepine , phenytoin ) or herbal supplements ( e.g. , St John 's wort ) that induce CYP3A4 activity and may result in reduced plasma concentrations of aprepitant and decreased efficacy of aprepitant .", "label": "", "metadata": {}, "score": "62.469284"}
{"text": "The present work aims to determine whether such ' class effects ' are present in bipolar disorder .On the basis of available evidence , several reviews and meta - analysis papers [ 12 - 16 ] developed tables concerning the efficacy of various agents in the different faces and facets of bipolar illness ( Table 1 ) .", "label": "", "metadata": {}, "score": "62.58011"}
{"text": "2008 May 22 .McVeigh JG , McGaughey H , Hall M , et al .The effectiveness of hydrotherapy in the management of fibromyalgia syndrome : a systematic review .", "label": "", "metadata": {}, "score": "62.593803"}
{"text": "Adolor reported results from two phase II trials of ADL5945 for chronic non - cancer opioid - induced constipation .The primary endpoint for both studies was the change from baseline in the weekly average of spontaneous bowel movements ( SBMs ) during treatment .", "label": "", "metadata": {}, "score": "62.758278"}
{"text": "Oral S - adenosylmethionine in primary fibromyalgia .Double - blind clinical evaluation .Scand J Rheumatol .Caruso I , Sarzi Puttini P , Cazzola M , et al .", "label": "", "metadata": {}, "score": "62.942986"}
{"text": "10.1176/appi.ps.57.5.660 .Levine J , Chengappa KN , Brar JS , Gershon S , Yablonsky E , Stapf D , Kupfer DJ : Psychotropic drug prescription patterns among patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "62.984596"}
{"text": "Results were presented at the 2003 Annual Meeting of the American Society of Gastroenterologists .June 2 , 2003 .Axcan Pharma reported positive results from a pilot study investigating mesalamine rectal gel , an anti - inflammatory agent for the treatment of ulcerative colitis .", "label": "", "metadata": {}, "score": "63.023865"}
{"text": "Phase II trials of NKTR-118 are currently underway .November 12 , 2007 .Movetis reported positive results from the first of three phase III trials of Resolor for the treatment of chronic constipation .", "label": "", "metadata": {}, "score": "63.06633"}
{"text": "10.1176/appi.ajp.161.6.1057 .PubMed .Khanna S , Vieta E , Lyons B , Grossman F , Eerdekens M , Kramer M : Risperidone in the treatment of acute mania : double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "63.083847"}
{"text": "Thase ME , Jonas A , Khan A , Bowden CL , Wu X , McQuade RD , Carson WH , Marcus RN , Owen R : Aripiprazole monotherapy in nonpsychotic bipolar I depression : results of 2 randomized , placebo - controlled studies .", "label": "", "metadata": {}, "score": "63.09279"}
{"text": "The?primary?efficacy ?measure?was?the?odds?of?negative?weekly ?urine?cannabinoid?test?results?during?treat- ment ? among ? participants ? receiving ?NAC ? compared ? with ? those ? receiving ? placebo , ? in?an?intent - to - treat ? analysis .", "label": "", "metadata": {}, "score": "63.128456"}
{"text": "There are some data concerning the efficacy of FGAs against acute mania but there are no data against bipolar depression or the maintenance phase .There is only one early , small , placebo - controlled study supporting the efficacy of chlorpromazine [ 43 ] .", "label": "", "metadata": {}, "score": "63.145527"}
{"text": "Yatham LN , Grossman F , Augustyns I , et al .Mood stabilizer plus risperidone or placebo in the treatment of acute mania : international , double - blind , randomized , controlled trial .", "label": "", "metadata": {}, "score": "63.18778"}
{"text": "International Forum on Mood and Anxiety Disorders .2003 , Monte Carlo , Monaco .Roy Chengappa KN , Schwarzman LK , Hulihan JF , Xiang J , Rosenthal NR : Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder : a randomized , placebo - controlled trial .", "label": "", "metadata": {}, "score": "63.269768"}
{"text": "Smoked MJ daily at least 25 days per month during the 90 days prior to randomization .Currently meets DSM IV criteria for dependence on substances , or has urine drug screen positive for substances , other than cannabis or nicotine .", "label": "", "metadata": {}, "score": "63.278843"}
{"text": "Gamber RG , Shores JH , Russo DP , et al .Osteopathic manipulative treatment in conjunction with medication relieves pain associated with fibromyalgia syndrome : results of a randomized clinical pilot project .", "label": "", "metadata": {}, "score": "63.292072"}
{"text": "Results showed eight out of ten subjects that started on placebo dropped out because of infectivity compared with none of the subjects taking ProBactrix .Data demonstrated significant improvement in bowel movement and mucus in stools among subjects taking ProBactrix .", "label": "", "metadata": {}, "score": "63.313255"}
{"text": "Cheng?W , ?Nunes ?EV : ? Dronabinol?for?the?treatment?of?cannabis?dependence : ? a ? randomized , ? double - blind , ? placebo - controlled ? trial .", "label": "", "metadata": {}, "score": "63.32109"}
{"text": "McCoy L , Votolato NA , Schwarzkopf SB , Nasrallah HA .Clinical correlates of valproate augmentation in refractory bipolar disorder .Ann Clin Psychiatry .", "label": "", "metadata": {}, "score": "63.366043"}
{"text": "Shopsin B , Gershon S , Thompson H , Collins P : Psychoactive drugs in mania .A controlled comparison of lithium carbonate , chlorpromazine , and haloperidol .", "label": "", "metadata": {}, "score": "63.403748"}
{"text": "Trans R Soc Trop Med Hyg .Berman BM , Ezzo J , Hadhazy V , et al .Is acupuncture effective in the treatment of fibromyalgia ?", "label": "", "metadata": {}, "score": "63.404"}
{"text": "A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia .Pain .Castro - S\u00e1nchez AM , Matar\u00e1n - Pe\u00f1arrocha GA , S\u00e1nchez - Labraca N , et al .", "label": "", "metadata": {}, "score": "63.406853"}
{"text": "One weekly evaluation occurred during the week 's scheduled clinic visit , and the other was a \" drop - in \" on a separate day of the week .", "label": "", "metadata": {}, "score": "63.489407"}
{"text": "Risperidone is efficacious against acute mania [ 46 , 85 - 87 ] .Recently , positive data concerning the maintenance phase became available for long - acting injectable risperidone , suggesting it is effective in the prevention of manic or mixed episodes but not depressive episodes [ 88 ] .", "label": "", "metadata": {}, "score": "63.509644"}
{"text": "The relapse rate in the aripiprazole group was significantly lower at 24 % versus 43 % in the placebo group .Aripiprazole was also superior to placebo in delaying the time to a manic episode , but failed to separate from placebo in delaying the time to a depressive episode .", "label": "", "metadata": {}, "score": "63.705112"}
{"text": "While the oxycodone / naloxone formulation could deter intravenous and possibly intranasal OxyContin abuse , it does not address oral abuse of the drug .NDA submission was originally planned for the end of 2002 .", "label": "", "metadata": {}, "score": "63.750175"}
{"text": "Only subjects with a positive response on the visual analog \" Liking \" scale of at least 20 points higher on active oxycodone vs. placebo will be eligible to continue in the double - blind 7-way crossover study .", "label": "", "metadata": {}, "score": "63.75672"}
{"text": "In addition , there was not a significant difference between divalproex and placebo in the time to a manic episode or time to a depressive episode .", "label": "", "metadata": {}, "score": "63.807045"}
{"text": "The earliest day at which a medication effect separates from placebo is one indication of how quickly a medication works .However , it is important to note that early placebo - controlled studies used day 7 as the first postrandomization measurement day , while more recent studies used day 2 .", "label": "", "metadata": {}, "score": "63.809067"}
{"text": "Nonetheless , our findings in this study repre- sent a key step in the development of inexpensive , readily available , safe , and efficacious pharmacotherapy for can- nabis dependence and should serve as a springboard for further investigation .", "label": "", "metadata": {}, "score": "64.0122"}
{"text": "The primary endpoints were assessed over the first 12 weeks of treatment an included two composite responder endpoints encompassing abdominal pain and complete spontaneous bowel movements ( CSBMs ) , as well as two individual responder endpoints for abdominal pain and CSBMs .", "label": "", "metadata": {}, "score": "64.01836"}
{"text": "There were no significant between - group differ- ences in baseline demographic or clinical variables .The groups had similar rates of positive urine cannabinoid tests at baseline .", "label": "", "metadata": {}, "score": "64.06599"}
{"text": "References : .Drugs Mentioned in This Article .Evidence - Based References .Calabrese JR , Vieta E , Shelton MD .Latest maintenance data on lamotrigine in bipolar disorder .", "label": "", "metadata": {}, "score": "64.10322"}
{"text": "10.1111/j.1399 -5618.2009.00748.x .PubMed .J Clin Psychopharmacol .PubMed .Arch Gen Psychiatry .10.1001/archpsyc.60.11.1079 .PubMed .Bech P : Meta - analysis of placebo - controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short - term treatment of major depression .", "label": "", "metadata": {}, "score": "64.13775"}
{"text": "Lamotrigine is associated with a benign rash in 10 % of patients .59 However , a slow titration schedule and dermatologic precautions ( avoiding new foods or allergens ) can reduce that risk to less than 5 % .", "label": "", "metadata": {}, "score": "64.219376"}
{"text": "Baldessarini R , Tondo L , Hennen J. Lithium treatment and suicide risk in major affective disorders : update and new findings .J Clin Psychiatry .", "label": "", "metadata": {}, "score": "64.22552"}
{"text": "Combination therapy also resulted in more weight gain , somnolence and , in the case of risperidone , EPS .Maintenance therapy .Maintenance therapy is an important component of treatment in bipolar disorder and can effectively reduce the rate of relapse .", "label": "", "metadata": {}, "score": "64.27506"}
{"text": "Avoidance of withdrawal symptoms ( e.g. , disturbances in mood , sleep , and craving ) is a common relapse precipitant .Cannabis use also impairs executive cognitive functions thereby increasing vulnerability to relapse and reducing the ability to benefit from behavioral therapy .", "label": "", "metadata": {}, "score": "64.31822"}
{"text": "50 However , lithium was found to be superior to lamotrigine in delaying the time to intervention for a manic episode .Lamotrigine was numerically , but not statistically , more effective than lithium in delaying the time to intervention for a depressive episode .", "label": "", "metadata": {}, "score": "64.34713"}
{"text": "2008 Aug 27 .Assefi N , Bogart A , Goldberg J , et al .Reiki for the treatment of fibromyalgia : a randomized controlled trial .", "label": "", "metadata": {}, "score": "64.45332"}
{"text": "Olanzapine versus divalproex .Olanzapine and divalproex were compared in a 47-week study involving 251 patients with an acute manic or mixed episode .", "label": "", "metadata": {}, "score": "64.45463"}
{"text": "June 30 , 2014 .AstraZeneca reported result of two pivotal phase III studies of naloxegol , an investigational treatment for opioid - induced constipation ( OIC ) .", "label": "", "metadata": {}, "score": "64.46723"}
{"text": "Kinon BJ , Gilmore JA .Long - term olanzapine treatment : weight change and weight - related health factors in schizophrenia .J Clin Psychiatry .", "label": "", "metadata": {}, "score": "64.49522"}
{"text": "These are com- parable to numbers needed to treat for several established addiction - targeted pharmacotherapies ( 38 ) .data supplement that accompanies the online edition of this article ) .", "label": "", "metadata": {}, "score": "64.51279"}
{"text": "10.1016/S0924 - 977X(03)00079 - 8 .PubMed .Goodwin GM , Bowden CL , Calabrese JR , Grunze H , Kasper S , White R , Greene P , Leadbetter R : A pooled analysis of 2 placebo - controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder .", "label": "", "metadata": {}, "score": "64.53111"}
{"text": "Employing microdialysis sampling , DETC - NAC levels in the nucleus accumbens ( NAc ) , medial prefrontal cortex ( mPFC ) , and plasma of rats treated with DSF reached 1.1 , 2.5 and 80nM at 6h .", "label": "", "metadata": {}, "score": "64.5719"}
{"text": "In contrast , there is strong evidence that during the maintenance phase , lamotrigine protects from depressive episodes but not from mania [ 36 - 40 ] .", "label": "", "metadata": {}, "score": "64.59675"}
{"text": "Additionally , as noted above , to be optimally implement- ed as a viable treatment , NAC must be investigated in a variety of psychosocial treatment contexts .", "label": "", "metadata": {}, "score": "64.61706"}
{"text": "Although not considered a primary end point in acute mania studies , completion rates may be an important measure of treatment effectiveness .An active medication may separate from placebo in clinical response , but a low completion rate raises questions as to the real - world effectiveness of the medication .", "label": "", "metadata": {}, "score": "64.64238"}
{"text": "Ali A , Njike VY , Northrup V , et al .Intravenous micronutrient therapy ( Myers ' Cocktail ) for fibromyalgia : a placebo - controlled pilot study .", "label": "", "metadata": {}, "score": "64.67015"}
{"text": "This led to a 4 \u00d7 4 crosstabulation with 16 ' agent class'/'treatment issue ' cases .Although such tables already exist in previous works , we created a new one on the basis of a fresh look at the available data .", "label": "", "metadata": {}, "score": "64.68036"}
{"text": "10.1016/j.jad.2009.10.007 .PubMed .Cookson J , Keck PE , Ketter TA , Macfadden W : Number needed to treat and time to response / remission for quetiapine monotherapy efficacy in acute bipolar depression : evidence from a large , randomized , placebo - controlled study .", "label": "", "metadata": {}, "score": "64.706955"}
{"text": "The subject has a history of significant neurological , hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , or metabolic disease .The subject has a history of an allergic reaction to oxycodone or structurally similar compounds ( morphine , hydromorphone , hydrocodone , levorphanol , pentazocine , codeine , etc . ) , naltrexone or other narcotic agonists .", "label": "", "metadata": {}, "score": "64.74515"}
{"text": "10.1192/bjp.bp.108.049965 .PubMed .Vieta E , Ramey T , Keller D , English P , Loebel A , Miceli J : Ziprasidone in the treatment of acute mania : a 12-week , placebo - controlled , haloperidol - referenced study .", "label": "", "metadata": {}, "score": "64.77031"}
{"text": "February 8 , 2016 .Synthetic Biologics reported results of a phase II trial of SYN-010 for the treatment of irritable bowel syndrome with constipation ( IBS - C ) .", "label": "", "metadata": {}, "score": "64.79381"}
{"text": "Neuropsychopharmacology ?Moussawi?K , ?Zhou?W , ?Shen?H , ?Reichel?CM , ?See?RE , ? Carr?DB , ? Kalivas?PW : ? Reversing?cocaine - induced?synaptic?potentiation ?", "label": "", "metadata": {}, "score": "64.82763"}
{"text": "Most clinicians and experts believe that typical antipsychotics induce the opposite pole and cause dysphoria and depression .However , this has only been reported concerning haloperidol and perphenazine , suggesting that they could decrease the time to switch into depression compared with atypical antipsychotics [ 49 , 50 ] .", "label": "", "metadata": {}, "score": "64.84912"}
{"text": "June 28 , 2004 .Xenova Group announced the combined results of two phase II trials of TA - CD , their vaccine candidate for abstinence initiation and relapse prevention in cocaine addiction .", "label": "", "metadata": {}, "score": "64.88691"}
{"text": "Presented at : American Psychiatric Association Annual Meeting ; May 20 - 25 , 2006 ; Toronto .Nguyen CT , Yu B , Maguire G. Update on atypicals : preemptive tactics to reduce weight gain .", "label": "", "metadata": {}, "score": "64.92064"}
{"text": "1999;60(suppl 2):77 - 84 .Solomon DA , Keitner GI , Miller IW , et al .Course of illness and maintenance treatments for patients with bipolar disorder .", "label": "", "metadata": {}, "score": "64.933105"}
{"text": "Standard descriptive statistics were used to summarize the general demographic and clinical data .Group differences in continuous characteristics were assessed using t tests , and differ- cy management and brief weekly cessation counseling , would be associated with higher rates of abstinence , as measured by the odds of negative urine cannabinoid test results during treatment .", "label": "", "metadata": {}, "score": "65.08492"}
{"text": "1999 , 53 ( Suppl ) : S67 - 72 .PubMed .Zarate CA , Tohen M , Baraibar G , Kando JC , Mirin J : Prescribing trends of antidepressants in bipolar depression .", "label": "", "metadata": {}, "score": "65.0985"}
{"text": "The aripiprazole study by Keck and colleagues 23 reported the lowest completion rates with only 42 % of patients in the aripiprazole arm and 21 % of patients in the placebo arm finishing the study .", "label": "", "metadata": {}, "score": "65.23509"}
{"text": "But , only some of these results lasted until the 1-year follow - up .Yoga is another alternative therapy that has been studied for fibromyalgia .", "label": "", "metadata": {}, "score": "65.26239"}
{"text": "March 9 , 2009 .Nektar Therapeutics released positive results from a phase II trial of NKTR-118 for the treatment of opioid - induced constipation ( OIC ) .", "label": "", "metadata": {}, "score": "65.43558"}
{"text": "October 20 , 2003 .Novartis reported positive results from a post - marketing trial investigating Zelnorm ( tegaserod maleate ) , an approved drug for the treatment of irritable bowel syndrome with constipation .", "label": "", "metadata": {}, "score": "65.492935"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT01611948 .Marijuana Abuse Chemically - Induced Disorders Mental Disorders Substance - Related Disorders Aprepitant Antiemetics Autonomic Agents Central Nervous System Agents .", "label": "", "metadata": {}, "score": "65.74398"}
{"text": "Titan Pharmaceuticals reported positive results from a pilot study investigating Probuphine ( buprenorphine ) for the treatment of opiate addiction .Results showed subjects were successfully switched to Probuphine with maintenance of treatment benefit , including absence of significant withdrawal or craving .", "label": "", "metadata": {}, "score": "65.75572"}
{"text": "PubMed Central PubMed .Fountoulakis KN , Gonda X , Vieta E , Schmidt F : Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy : a meta - analysis .", "label": "", "metadata": {}, "score": "65.893936"}
{"text": "PubMed .Fountoulakis KN , Vieta E : Efficacy and safety of aripiprazole in the treatment of bipolar disorder : a systematic review .Ann Gen Psychiatry .", "label": "", "metadata": {}, "score": "65.90731"}
{"text": "Sucampo Pharmaceuticals reported positive results from a phase III trial investigating SPI-0211 , a chloride channel activator for the treatment of constipation .Results showed the treatment performed significantly better than placebo for all constipation variables tested .", "label": "", "metadata": {}, "score": "66.024155"}
{"text": "An update of selected recent research .Harv Rev Psychiatry .Calabrese JR , Vieta E , Shelton MD .Latest maintenance data on lamotrigine in bipolar disorder .", "label": "", "metadata": {}, "score": "66.04192"}
{"text": "Haanen HC , Hoenderdos HT , van Romunde LK , et al .Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia .J Rheumatol .", "label": "", "metadata": {}, "score": "66.11043"}
{"text": "Additional behavior modifications have also been effective in mitigating weight gain ( Table 2 ) .These trials demonstrate that behavioral modifications can significantly decrease weight gain associated with mood stabilizer and antipsychotic medications .", "label": "", "metadata": {}, "score": "66.1363"}
{"text": "Kalivas ?PW , ?LaLumiere ?R , ?Knackstedt ?L , ?Shen ?H : ?Glutamate ?transmission?in?addiction .Neuropharmacology ? 56(suppl ?", "label": "", "metadata": {}, "score": "66.173195"}
{"text": "This means that the whole ' class ' of drugs is considered to possesses a specific therapeutic action that in some cases has been proven only for a few of its members or even only for a single one .", "label": "", "metadata": {}, "score": "66.18848"}
{"text": "Additionally , improvements were achieved in pre - specified secondary endpoints in this trial covering abdominal and constipation symptoms , including bloating and abdominal pain / discomfort .", "label": "", "metadata": {}, "score": "66.35373"}
{"text": "Adverse events leading to study discontinuation did not differ between groups .Olanzapine was associated with more somnolence , dry mouth , increased appetite , weight gain , akathisia , elevated cholesterol level , and elevated liver function tests .", "label": "", "metadata": {}, "score": "66.36673"}
{"text": "Lamotrigine was superior to placebo in delaying time to intervention for any mood episode and time to intervention for a depressive episode .Lamotrigine did not separate from placebo in delaying time to intervention for a manic episode in either study , but a combined analysis of both studies found a significant difference .", "label": "", "metadata": {}, "score": "66.42324"}
{"text": "At the same time , the data are negative for paroxetine monotherapy [ 103 ] and equivocal for venlafaxine , possibly because of a high switch rate [ 104 ] .", "label": "", "metadata": {}, "score": "66.4326"}
{"text": "The effect of guided imagery and amitriptyline on daily fibromyalgia pain : a prospective , randomized , controlled trial .J Psychiatr Res .Sunshine W , Field T , Quintino O , et al .", "label": "", "metadata": {}, "score": "66.48224"}
{"text": "Exclusion Criteria : .The subject has a positive urine drug screen or ethanol breath test at check - in to the clinic .The subject has been taking prescription opioids daily for chronic pain or has been taking illicit or prescription opioids daily for recreational purposes for more than 20 days in the last month .", "label": "", "metadata": {}, "score": "66.61882"}
{"text": "ajp.psychiatryonline.org Am J Psychiatry 169:8 , August 2012 adverse consequences of adolescent cannabis use and the limited abstinence rates produced by existing treatments , these findings provide an important addition to the evi- dence base .", "label": "", "metadata": {}, "score": "66.66318"}
{"text": "J Affect Disord .10.1016/j.jad.2006.01.024 .PubMed .J Clin Psychiatry .10.4088/JCP.08m04942gre .PubMed .Vieta E , Martinez - Aran A , Goikolea JM , Torrent C , Colom F , Benabarre A , Reinares M : A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers .", "label": "", "metadata": {}, "score": "66.677475"}
{"text": "Ironwood and Forest Laboratories reported positive results from a phase III trial of linaclotide for the treatment of irritable bowel syndrome with constipation ( IBS - C ) .", "label": "", "metadata": {}, "score": "66.720245"}
{"text": "Drug : oxycodone and naltrexone ./ tablets containing 20 mg or 40 mg oxycodone combined w/0.001 mg or 0.0001 mg naltrexone .Detailed Description : .", "label": "", "metadata": {}, "score": "66.81414"}
{"text": "10.1176/appi.ajp.163.2.247 .PubMed .Tohen M , Sutton VK , Calabrese JR , Sachs GS , Bowden CL : Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized , double - blind , placebo - controlled study of bipolar 1 disorder .", "label": "", "metadata": {}, "score": "66.91171"}
{"text": "Abstract .Background .Anecdotal reports suggests that most clinicians treat medications as belonging to a class with regard to all therapeutic indications ; this means that the whole ' class ' of drugs is considered to possesses a specific therapeutic action .", "label": "", "metadata": {}, "score": "66.98071"}
{"text": "Therefore , it is crucial that a prophylactic treatment plan be implemented .While effective treatments for acute mania and bipolar prophylaxis are available , they are not without risk .", "label": "", "metadata": {}, "score": "67.02284"}
{"text": "\"The?Cannabis?Youth?Treatment ?( CYT ) ? study : ? main?findings?from?two?randomized?trials . \" J?Subst ?Abuse?Treat ?Dennis?M , ? Godley?SH , ? Diamond?G , ? Tims?FM , ?", "label": "", "metadata": {}, "score": "67.047264"}
{"text": "Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania .Am J Psychiatry .Hirschfeld RM , Baker JD , Wozniak PJ , et al .", "label": "", "metadata": {}, "score": "67.06694"}
{"text": "Numerous studies have analyzed this concept with valproate / divalproex .Several studies showed that when oral ( \" rapid \" ) loading doses of valproate / divalproex are used , most patients have significant improvement in manic symptoms by day 5 , with the greatest percent change on the MRS occurring in the first 3 days of treatment .", "label": "", "metadata": {}, "score": "67.19345"}
{"text": "An MAA is currently under review by the EMEA and Swissmedic .September 29 , 2008 .Sucampo issued positive results from a phase IIb trial of Amitiza for the treatment of Chronic Idiopathic Constipation .", "label": "", "metadata": {}, "score": "67.1971"}
{"text": "Treatment of fibromyalgia with formula acupuncture : investigation of needle placement , needle stimulation , and treatment frequency .J Altern Complement Med .Smania N , Corato E , Fiaschi A , et al .", "label": "", "metadata": {}, "score": "67.209076"}
{"text": "A double - blind crossover study .Am J Med .1987;83(5A):107 - 110 .Tavoni A , Jeracitano G , Cirigliano G. Evaluation of S - adenosylmethionine in secondary fibromyalgia : a double - blind study .", "label": "", "metadata": {}, "score": "67.27033"}
{"text": "10.1016/j.jad.2008.11.003 .PubMed .Brown E , Dunner DL , McElroy SL , Keck PE , Adams DH , Degenhardt E , Tohen M , Houston JP : Olanzapine / fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression .", "label": "", "metadata": {}, "score": "67.36788"}
{"text": "10.1176/appi.ajp.2008.08020189 .PubMed .Keck PE , Marcus R , Tourkodimitris S , Ali M , Liebeskind A , Saha A , Ingenito G : A placebo - controlled , double - blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania .", "label": "", "metadata": {}, "score": "67.38652"}
{"text": "10.1034/j.1399 - 5618.2000.020205.x .PubMed .Baldessarini RJ , Leahy L , Arcona S , Gause D , Zhang W , Hennen J : Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders .", "label": "", "metadata": {}, "score": "67.39764"}
{"text": "Clin Rehabil .Mendonca ME , Santana MB , Baptista AF , et al .Transcranial DC stimulation in fibromyalgia : optimized cortical target supported by high - resolution computational models .", "label": "", "metadata": {}, "score": "67.40474"}
{"text": "10.1016/j.jad.2009.11.014 .PubMed .Calabrese JR , Keck PE , Macfadden W , Minkwitz M , Ketter TA , Weisler RH , Cutler AJ , McCoy R , Wilson E , Mullen J : A randomized , double - blind , placebo - controlled trial of quetiapine in the treatment of bipolar I or II depression .", "label": "", "metadata": {}, "score": "67.42177"}
{"text": "Based on the results .Movetis plans to file for European regulatory approval in mid-2008 .September 24 , 2007 .Nektar issued positive results from a phase I trial of NKTR-118 for the treatment of opioid bowel dysfunction ( OBD ) .", "label": "", "metadata": {}, "score": "67.4829"}
{"text": "An unpublished poster presentation from Japan reported that Japanese psychiatrists were divided between antidepressants and ' mood stabilizers ' on the treatment of bipolar depression [ 137 ] .", "label": "", "metadata": {}, "score": "67.54019"}
{"text": "10.1016/j.jad.2009.12.028 .PubMed .Vieta E , Nuamah IF , Lim P , Yuen EC , Palumbo JM , Hough DW , Berwaerts J : A randomized , placebo- and active - controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder .", "label": "", "metadata": {}, "score": "67.573555"}
{"text": "Four double - blind trials have studied the use of SAMe for fibromyalgia , 6 - 9 three of them finding it to be helpful .", "label": "", "metadata": {}, "score": "67.682816"}
{"text": "Ball PM , Coons VB , Buchanan RW .A program for treating olanzapinerelated weight gain .Psychiatr Serv .Centorrino F , Wurtman JJ , Duca KA , et al .", "label": "", "metadata": {}, "score": "67.73231"}
{"text": "management?for?adolescent?smoking?cessation .J?Subst?Abuse ?Treat ?40:77 - 86 the?Mini?International?Neuropsychiatric?Interview?for?Children ?and?Adolescents ?( MINI - KID ) .J?Clin?Psychiatry ? First?MB , ? Spitzer?RL , ?", "label": "", "metadata": {}, "score": "67.754"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable . \"Disulfiram ( DSF ; PubChem CID : 3117 ) , originally identified as a treatment for alcohol addiction [ 1 ] , has now been found to also have potential for the treatment of several other substance use disorders .", "label": "", "metadata": {}, "score": "67.76901"}
{"text": "Progenics and Wyeth reported positive results from an open label phase III extension trial of subcutaneous methylnaltrexone ( MNTX ) for the treatment of opioid - induced constipation ( OIC ) .", "label": "", "metadata": {}, "score": "67.77892"}
{"text": "10.1016/j.euroneuro.2004.06.003 .PubMed .Young A , Oren D , Lowy A , McQuade RD , Marcus RN , Carson W , Spiller N , Torbeyns A , Sanchez R : Aripiprazol monotherapy in acute mania : a 12-week , randomized , placebo and haloperidol- controlled study .", "label": "", "metadata": {}, "score": "67.82115"}
{"text": "To enhance the blind , a small amount of NAC powder was applied to the inside of all blis- ter packs so that both NAC and placebo packs would contain the scent of NAC .", "label": "", "metadata": {}, "score": "67.83843"}
{"text": "( odds ?Exploratory?secondary?absti- nence ? outcomes ? favored ?NAC ? but ? were ? not?statistically?significant .NAC?was?well ? tolerated , ? with?minimal?adverse?events .Conclusions : ? This?is?the?first?randomized ? controlled ? trial ? of ? pharmacotherapy ? for ?", "label": "", "metadata": {}, "score": "67.88569"}
{"text": "Aripiprazole is efficacious against acute mania [ 78 - 80 ] although one RCT with a fixed dosage design was negative [ 81 ] .Data are negative concerning bipolar depression [ 82 ] .", "label": "", "metadata": {}, "score": "67.90311"}
{"text": "PubMed .Amsterdam JD , Garcia - Espana F , Fawcett J , Quitkin FM , Reimherr FW , Rosenbaum JF , Schweizer E , Beasley C : Efficacy and safety of fluoxetine in treating bipolar II major depressive episode .", "label": "", "metadata": {}, "score": "67.98218"}
{"text": "PubMed .The Depakote Mania Study Group .JAMA .10.1001/jama.271.12.918 .PubMed .Bowden CL , Swann AC , Calabrese JR , Rubenfaer LM , Wozniak PJ , Collins MA , Abi - Saab W , Saltarelli M : A randomized , placebo - controlled , multicenter study of divalproex sodium extended release in the treatment of acute mania .", "label": "", "metadata": {}, "score": "68.01223"}
{"text": "Outcome Measures efficacy .Urine cannabinoid testing at baseline , during weekly clinic visits , and at the posttreatment follow - up , was conducted as the primary biological measure of cannabis use .", "label": "", "metadata": {}, "score": "68.12666"}
{"text": "Page 7 .GRAy , CARPeNTeR , BAKeR , eT Al .Am J Psychiatry 169:8 , August 2012 ajp.psychiatryonline.org 811 9 .Levin?FR , ? Mariani?JJ , ? Brooks?DJ , ?", "label": "", "metadata": {}, "score": "68.13419"}
{"text": "DETC - NAC and internal standards were recovered at better than 95 % from all matrices , perchloric acid precipitation ( plasma ) or formic acid addition ( salt ) and is stable in plasma or salt at low pH for up to 24h .", "label": "", "metadata": {}, "score": "68.14992"}
{"text": "PubMed .Ghaemi SN , Hsu DJ , Thase ME , Wisniewski SR , Nierenberg AA , Miyahara S , Sachs G : Pharmacological treatment patterns at study entry for the first 500 STEP - BD participants .", "label": "", "metadata": {}, "score": "68.161224"}
{"text": "10.1016/j.jad.2009.11.008 .PubMed .Smith LA , Cornelius VR , Azorin JM , Perugi G , Vieta E , Young AH , Bowden CL : Valproate for the treatment of acute bipolar depression : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "68.18727"}
{"text": "J Musculoskelet Pain .Massey PB .Reduction of fibromyalgia symptoms through intravenous nutrient therapy : results of a pilot clinical trial .Altern Ther Health Med .", "label": "", "metadata": {}, "score": "68.190704"}
{"text": "J Rheumatol .Abraham GE , Flechas JD .Management of fibromyalgia : rationale for the use of magnesium and malic acid .J Nutr Med .", "label": "", "metadata": {}, "score": "68.192566"}
{"text": "Treatment of fibromyalgia syndrome with Super Malic \u00ae : a randomized , double blind , placebo controlled , crossover pilot study .J Rheumatol .Russell IJ , Michalek JE , Flechas JD , et al .", "label": "", "metadata": {}, "score": "68.29613"}
{"text": "Castro - S\u00e1nchez AM , Matar\u00e1n - Pe\u00f1arrocha GA , Arroyo - Morales M , Saavedra - Hern\u00e1ndez M , Fern\u00e1ndez - Sola C , Moreno - Lorenzo C. Effects of myofascial release techniques on pain , physical function , and postural stability in patients with fibromyalgia : a randomized controlled trial .", "label": "", "metadata": {}, "score": "68.37186"}
{"text": "Treatment was generally well tolerated .Based on the results , Sucampo is planning to commence phase III trials in Japan .May 12 , 2008 .", "label": "", "metadata": {}, "score": "68.37903"}
{"text": "PubMed .Post RM , Altshuler LL , Frye MA , Suppes T , Rush AJ , Keck PE , McElroy SL , Denicoff KD , Leverich GS , Kupka R , Nolen WA : Rate of switch in bipolar patients prospectively treated with second - generation antidepressants as augmentation to mood stabilizers .", "label": "", "metadata": {}, "score": "68.42225"}
{"text": "The median number of days retained in the study was 63 days ( interquartile range , 13 - 66 ) in the NAC group and 62 days ( interquartile range , 17 - 65 ) in the pla- cebo group .", "label": "", "metadata": {}, "score": "68.43203"}
{"text": "10.4088/JCP.v67n0414 .PubMed .Keck PE , Calabrese JR , McIntyre RS , McQuade RD , Carson WH , Eudicone JM , Carlson BX , Marcus RN , Sanchez R : Aripiprazole monotherapy for maintenance therapy in bipolar I disorder : a 100-week , double - blind study versus placebo .", "label": "", "metadata": {}, "score": "68.46265"}
{"text": "Safety and tolerability .Adherence .Medication diaries and weekly pill counts ( inspec- tion of blister packs and documentation of missed doses ) were used to measure adherence .", "label": "", "metadata": {}, "score": "68.55707"}
{"text": "Pope HG Jr , McElroy SL , Keck PE Jr , Hudson JI .Valproate in the treatment of acute mania : a placebo - controlled study .", "label": "", "metadata": {}, "score": "68.55976"}
{"text": "Similarly , our knowledge and understanding of treatment has progressed , largely following our understanding of the clinical picture .The first dramatic conclusion was that the outcome of bipolar illness is not favorable as Kraepelin had determined , but rather suboptimal and is strongly related to younger age of onset and to alcohol and substance abuse .", "label": "", "metadata": {}, "score": "68.581436"}
{"text": "It is thought to work by increasing the amount of serotonin in the brain .However , evidence that it helps fibromyalgia is still preliminary .", "label": "", "metadata": {}, "score": "68.6833"}
{"text": "The figure above shows the increase in the size of dendritic spines ( where synaptic connections are made ) during cocaine relapse .Notice how much bigger the spines are in the animal that has relapses for 15 min .", "label": "", "metadata": {}, "score": "68.688416"}
{"text": "Dr. Brady has received research funding from Glaxo SmithKline .The other authors report no financial relationships with commercial interests .Supported by National Institute on Drug Abuse ( NIDA ) grant R01DA026777 , via the American Recovery and Reinvestment Act of 2009 .", "label": "", "metadata": {}, "score": "68.69858"}
{"text": "Akiskal HS , Pinto O : The evolving bipolar spectrum .Prototypes I , II , III , and IV .Psychiatr Clin North Am .", "label": "", "metadata": {}, "score": "68.83885"}
{"text": "J Clin Psychiatry .Hirschfeld MA , Lewis L , Vornik LA .Perceptions and impact of bipolar disorder : how far have we really come ?", "label": "", "metadata": {}, "score": "68.84525"}
{"text": "11 They also noted improvements in sleep patterns , morning stiffness , anxiety , and fatigue .Interestingly , the people taking placebo also noted significant improvements in pain and sleep , although less marked than those experienced with 5-HTP .", "label": "", "metadata": {}, "score": "68.8521"}
{"text": "In ESENSE1 and -2 all assessments were consistently in favor of nalmefene compared to placebo .Overall , nalmefene reduced heavy drinking days and total alcohol consumption by more than 50 % compared to pre - treatment baseline .", "label": "", "metadata": {}, "score": "68.92956"}
{"text": "Consistent with previous phase III trials of linaclotide , the most common adverse event reported in linaclotide - treated patients was diarrhea .Both the 72mcg and 145mcg linaclotide doses were generally well - tolerated in the trial .", "label": "", "metadata": {}, "score": "68.95067"}
{"text": "Up to 50 % of patients with bipolar disorder will attempt suicide and as many as 20 % will complete suicide .5 Given these serious consequences , it is important to implement a treatment plan that treats bipolar episodes rapidly and effectively .", "label": "", "metadata": {}, "score": "69.012405"}
{"text": "After receiving a complete descrip- tion of the study , all participants age 18 years or older provided written consent ; written parental consent and participant assent were obtained for those under age 18 .", "label": "", "metadata": {}, "score": "69.08554"}
{"text": "The NDA is under Priority Review by the FDA .December 15 , 2014 .Orexo released results of a phase III trial of Zubsolv compared with Suboxone film during stabilization of patients with opioid dependence .", "label": "", "metadata": {}, "score": "69.14152"}
{"text": "In contrast , suppressing NAC - induced restoration of GLT-1 not only prevented NAC from inhibiting reinstatement , but augmented the capacity of cues to reinstate cocaine seeking .", "label": "", "metadata": {}, "score": "69.17995"}
{"text": "Stanger?C , ? Budney?AJ , ? Kamon?JL , ?Thostensen?J : ? A?randomized ? trial ? of ? contingency ? management ? for ? adolescent ? marijuana ?", "label": "", "metadata": {}, "score": "69.19133"}
{"text": "Baldessarini RJ , Tondo L , Hennen J. Treating the suicidal patient with bipolar disorder : reducing suicide risk with lithium .Ann NY Acad Sci .", "label": "", "metadata": {}, "score": "69.20951"}
{"text": "The subject is willing and able to comply with all testing and requirements defined in the protocol .The subject must agree to refrain from caffeine and xanthine - containing products throughout the study , and to refrain from nicotine from 1 hour prior to each dosing until 4 hours after each dosing .", "label": "", "metadata": {}, "score": "69.262886"}
{"text": "The vaccine also yielded a significant reduction in consumption and nicotine dependence among non - quitters at its highest dose , compared with placebo .NicVAX treatment was safe and well tolerated .", "label": "", "metadata": {}, "score": "69.37182"}
{"text": "One study purportedly found that use of cosmetics increases fibromyalgia symptoms , but it was too poorly designed to show anything at all .42 An equally meaningless study purported to show that intravenous nutrients are helpful for fibromyalgia .", "label": "", "metadata": {}, "score": "69.462585"}
{"text": "Today we know that the treatment of bipolar illness is complex and full of caveats for the clinician [ 8 - 11 ] , with some aspects of the disorder being rather refractory to treatment .", "label": "", "metadata": {}, "score": "69.5296"}
{"text": "17,18,22 Up to 6 mg / d of lorazepam from days 1 through 4 in the aripiprazole studies was allowed .Quetiapine studies also allowed 6 mg / d of lorazepam from days 1 through 4 . 19,20 Furthermore , in the quetiapine study by Bowden and colleagues , 19 chloral hydrate at dosages of 2000 mg / d was allowed from days 1 through 7 and up to 1000 mg / d from days 8 through 84 .", "label": "", "metadata": {}, "score": "69.558945"}
{"text": "1981 , 138 : 256- PubMed .Davis LL , Bartolucci A , Petty F : Divalproex in the treatment of bipolar depression : a placebo - controlled study .", "label": "", "metadata": {}, "score": "69.567215"}
{"text": "10.1016/j.eurpsy.2007.01.1218 .PubMed .Tohen M , Calabrese JR , Sachs GS , Banov MD , Detke HC , Risser R , Baker RW , Chou JC , Bowden CL : Randomized , placebo - controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine .", "label": "", "metadata": {}, "score": "69.61142"}
{"text": "Quetiapine has proven efficacy against acute mania [ 45 , 65 , 66 ] , including an unpublished study ( NCT00309699 ) .The data are solid also against acute bipolar depression [ 67 - 74 ] and they are also effective against depression in bipolar II depression [ 75 ] .", "label": "", "metadata": {}, "score": "69.645836"}
{"text": "Mayhew E , Ernst E. Acupuncture for fibromyalgia - a systematic review of randomized clinical trials .Rheumatology ( Oxford ) .2006 Dec 19 .", "label": "", "metadata": {}, "score": "69.79848"}
{"text": "PubMed .Calabrese JR , Bowden CL , Sachs GS , Ascher JA , Monaghan E , Rudd GD : A double - blind placebo - controlled study of lamotrigine monotherapy in outpatients with bipolar I depression .", "label": "", "metadata": {}, "score": "69.81941"}
{"text": "Most naloxegol - emergent gastrointestinal adverse events ( AEs ) occurred early in treatment and were transient with nine patients ( 1.6 % ) discontinuing naloxegol due to abdominal pain .", "label": "", "metadata": {}, "score": "69.82587"}
{"text": "SGA dosing : combination therapy versus monotherapy .No clinical trials to date have directly compared SGA combination therapy versus SGA monotherapy .Nevertheless , it is helpful to analyze the efficacy and dosing of SGA polytherapy and SGA monotherapy trials when deciding upon treatment medications .", "label": "", "metadata": {}, "score": "69.92323"}
{"text": "Thus , by inhibiting cAMP kinase , relapse reverses abstinence - induced neuroadaptations in the addiction circuitry that are responsible , in part , for the ability of environmental cues to induce cocaine seeking .", "label": "", "metadata": {}, "score": "70.0519"}
{"text": "Institute?for?Social?Research , ? Chen?CY , ?Anthony?JC : ? Possible?age - associated?bias?in?report- ing?of?clinical?features?of?drug?dependence : ? epidemiological ?evidence?of?adolescent - onset?marijuana?use .Addiction ?Rey?JM , ?", "label": "", "metadata": {}, "score": "70.08219"}
{"text": "Here we describe a LCMS / MS method on a QQQ type instrument to quantify DETC - NAC in plasma and intracellular fluid from mammalian brain .", "label": "", "metadata": {}, "score": "70.082825"}
{"text": "10.4088/JCP.v63n0607 .PubMed .Rosa AR , Cruz N , Franco C , Haro JM , Bertsch J , Reed C , Aarre TF , Sanchez - Moreno J , Vieta E : Why do clinicians maintain antidepressants in some patients with acute mania ?", "label": "", "metadata": {}, "score": "70.152466"}
{"text": "10.4088/JCP.v67n0703 .PubMed .Clin Ther .10.1016/S0149 - 2918(04)90013 - 6 .PubMed .Dube S , Tollefson GD , Thase ME , Briggs SD , Van Campen LE , Case M , Tohen M : Onset of antidepressant effect of olanzapine and olanzapine / fluoxetine combination in bipolar depression .", "label": "", "metadata": {}, "score": "70.15318"}
{"text": "Later trials found that SGAs are also efficacious in reducing the duration of manic episodes .It has been hypothesized that SGAs decrease dopamine transmission through blockade or partial agonism of dopamine D 2 receptors .", "label": "", "metadata": {}, "score": "70.16371"}
{"text": "Leo?GI , ?Cancilla?A : ? Reliability?of?a?timeline ? method : ? assessing?normal?drinkers ' ?reports?of?recent?drinking ?and?a?comparative?evaluation?across?several?populations .Br?J ?Addict ? National?Institute?on?Drug?Abuse : ?Marijuana : ? Facts?for?Teens , ?", "label": "", "metadata": {}, "score": "70.31055"}
{"text": "While evidence - based medicine has seemed to dominate medical scientific thinking in the last few decades , this is not true for wider clinical practice .", "label": "", "metadata": {}, "score": "70.585556"}
{"text": "Fountoulakis KN , Vieta E , Sanchez - Moreno J , Kaprinis SG , Goikolea JM , Kaprinis GS : Treatment guidelines for bipolar disorder : a critical review .", "label": "", "metadata": {}, "score": "70.58941"}
{"text": "Addict?Biol ?Dean?O , ?Giorlando?F , ?Berk?M : ? N - acetylcysteine ? in?psychiatry : ?current?therapeutic?evidence?and?potential?mechanisms?of?ac- tion .J?Psychiatry?Neurosci ? Gray?KM , ? Watson?NL , ? Carpenter?MJ , ?", "label": "", "metadata": {}, "score": "70.59253"}
{"text": "At day 15 , Zubsolv patients switched to Suboxone film and those taking Suboxone film switched to Zubsolv .The co - primary endpoint was retention in treatment at day 15 .", "label": "", "metadata": {}, "score": "70.71451"}
{"text": "XR - NTX was generally well tolerated .December 11 , 2006 .Somaxon reported negative results from a phase II / III trial of nalmefene for the treatment of pathological gambling .", "label": "", "metadata": {}, "score": "70.793396"}
{"text": "Research interest in NAC has grown amid increasing evi- dence of the role of the neurotransmitter glutamate in ad- diction ( 10 - 12 ) .", "label": "", "metadata": {}, "score": "70.85811"}
{"text": "The primary endpoint , mean PG - YBOCS ( Yale Brown Obsessive Compulsive Scale modified for Pathological Gambling ) as measured at week twelve , was not met .", "label": "", "metadata": {}, "score": "70.92997"}
{"text": "[ Time Frame : At 30 , 60 , 90 , 120 , 150 , 180 and 210 minutes post - dose ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "70.99636"}
{"text": "[ Time Frame : At 30 , 60 , 90 , 120 , 150 , 180 and 210 minutes post - dose ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "70.99636"}
{"text": "Titan and Braeburn intend to resubmit an NDA for Probuphine to the FDA in the second half of this year .The NDA is still considered to be under Priority Review by the FDA .", "label": "", "metadata": {}, "score": "71.050476"}
{"text": "adverse ? events , ? compared ? by ? treatment ? group .Results : ? Participants?receiving?NAC?had ? more ? than ? twice ?the ? odds , ? compared ? with ? those ? receiving ? placebo , ? of ? having ?", "label": "", "metadata": {}, "score": "71.08735"}
{"text": "J Clin Psychiatry .10.4088/JCP.v64n0906 .PubMed .Calabrese JR , Goldberg JF , Ketter TA , Suppes T , Frye M , White R , DeVeaugh - Geiss A , Thompson TR : Recurrence in bipolar I disorder : a post hoc analysis excluding relapses in two double - blind maintenance studies .", "label": "", "metadata": {}, "score": "71.13487"}
{"text": "When a light / tone cue that had previously been shown only when cocaine was self - administered caused the rats to relapse , the activation of these proteins was reduced .", "label": "", "metadata": {}, "score": "71.192085"}
{"text": "Krabman?P : ? Is?the?party?over ? ? cannabis?and ? juvenile ? psychiatric ? disorder : ? the ? past ? years .J ?Am ?Acad ?", "label": "", "metadata": {}, "score": "71.21384"}
{"text": "To date , the mechanism of this interaction has not been determined .A recent in vitro study suggested that the toxic metabolite N - acetyl - para - benzoquinoneimine ( NAPQI ) appeared to interfere with vitamin K - dependent \u03b3 - carboxylase ( VKD - carb ) and vitamin K epoxide reductase ( VKOR ) activites12 .", "label": "", "metadata": {}, "score": "71.242325"}
{"text": "It involves the presence of widespread chronic pain and the existence of pain in at least 11 of 18 specific points on the body when pressure is applied .", "label": "", "metadata": {}, "score": "71.245094"}
{"text": "Declarations .Competing interests .KNF is / was member of the International Consultation Board of Wyeth for desvenlafaxine , BMS for aripiprazole in bipolar disorder and Servier for agomelatine and has received honoraria for lectures from AstraZeneca , Janssen - Cilag , Eli Lilly and research grants from AstraZeneca and Pfizer Foundation .", "label": "", "metadata": {}, "score": "71.29097"}
{"text": "Jacobsen S , Danneskiold - Samsoe B , Andersen RB .Oral S - adenosylmethionine in primary fibromyalgia .Double - blind clinical evaluation .Scand J Rheumatol .", "label": "", "metadata": {}, "score": "71.32953"}
{"text": "TD 1211 was generally well tolerated .The most frequent adverse events were abdominal pain , nausea , diarrhea and headache .Theravance noted that the results support progression into phase III development .", "label": "", "metadata": {}, "score": "71.355705"}
{"text": "15 min after inducing relapse synaptic connections were increased in size and strength , and went back to pre - relapse levels by 45 min , at the same time the relapse - induced lever pressing ended .", "label": "", "metadata": {}, "score": "71.43532"}
{"text": "Results were presented today at the 68th Annual Scientific Meeting of the American College of Gastroenterology .July 14 , 2003 .The BioBalance Corp. reported positive results from a pilot study investigating Probactrix , a probiotic oral suspension for the treatment of irritable bowel syndrome ( IBS ) .", "label": "", "metadata": {}, "score": "71.51444"}
{"text": "2009 , 8 : 27 - 10.1186/1744 - 859X-8 - 27 .PubMed Central PubMed .Fountoulakis KN , Vieta E : Treatment of bipolar disorder : a systematic review of available data and clinical perspectives .", "label": "", "metadata": {}, "score": "71.611115"}
{"text": "Utilizing exercise to affect the symptomology of fibromyalgia : a pilot study .Med Sci Sports Exerc .Tavoni A , Vitali C , Bombardieri S , et al .", "label": "", "metadata": {}, "score": "71.635605"}
{"text": "Ng B , Camacho A , Lara DR , Brunstein MG , Pinto OC , Akiskal HS : A case series on the hypothesized connection between dementia and bipolar spectrum disorders : bipolar type VI ?", "label": "", "metadata": {}, "score": "71.774185"}
{"text": "10.1007/BF00431111 .Goldsmith DR , Wagstaff AJ , Ibbotson T , Perry CM : Lamotrigine : a review of its use in bipolar disorder .", "label": "", "metadata": {}, "score": "71.79826"}
{"text": "PubMed .Klein E , Bental E , Lerer B , Belmaker RH : Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses .A controlled study .", "label": "", "metadata": {}, "score": "72.03404"}
{"text": "medications?for?the?treatment?of?drug?and?behavioral?addic- tions .Pharmacol?Biochem?Behav ?Moussawi?K , ?Pacchioni?A , ?Moran?M , ? Olive?MF , ? Gass?JT , ?Lavin?A , ? Kalivas?PW : ? N - Acetylcysteine ?", "label": "", "metadata": {}, "score": "72.03642"}
{"text": "Dr. Kevin Gray is an Associate Professor of Psychiatry at MUSC , and is the recipient of a NARC pilot award to support his studies on the use of N - acetylcysteine to treat cocaine relapse .", "label": "", "metadata": {}, "score": "72.118515"}
{"text": "Arch Gen Psychiatry .10.1001/archpsyc.60.12.1218 .PubMed .Zarate CA , Tohen M : Double - blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients .", "label": "", "metadata": {}, "score": "72.12187"}
{"text": "10.1016/j.jad.2006.05.023 .PubMed .N Engl J Med .10.1056/NEJMoa064135 .PubMed .Young LT , Joffe RT , Robb JC , MacQueen GM , Marriott M , Patelis - Siotis I : Double - blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression .", "label": "", "metadata": {}, "score": "72.24891"}
{"text": "10.1016/j.jad.2005.01.004 .PubMed .Fountoulakis KN , Vieta E , Siamouli M , Valenti M , Magiria S , Oral T , Fresno D , Giannakopoulos P , Kaprinis GS : Treatment of bipolar disorder : a complex treatment for a multi - faceted disorder .", "label": "", "metadata": {}, "score": "72.25963"}
{"text": "ajp.psychiatryonline.org Am J Psychiatry 169:8 , August 2012 controlled?trial .Am?J?Drug?Alcohol?Abuse ? Zeger?SL , ?Liang?KY : ? Longitudinal?data?analysis?for?discrete?and ?continuous?outcomes .Biometrics ? Pan?W : ?", "label": "", "metadata": {}, "score": "72.38836"}
{"text": "The majority of mood stabilizers and antipsychotics used in the treatment of bipolar disorder are associated with significant adverse effects .Commonly reported adverse events include weight gain , somnolence , tremor , rash , and EPS .", "label": "", "metadata": {}, "score": "72.40909"}
{"text": "Active suicidal ideation .Significant medical disorders that will increase potential risk or interfere with study participation , .Females who are pregnant , nursing or who are sexually active with child - bearing potential and refuse to use a double - barrier method of birth control during the study and for up to 4 weeks after study termination .", "label": "", "metadata": {}, "score": "72.4384"}
{"text": "Synergy also is conducting a phase IIb study in IBS with constipation ( IBS - C ) .July 16 , 2012 .Theravance released results from a phase IIb trial of TD-1211 for the treatment of opioid - induced constipation ( OIC ) in chronic , non - cancer pain .", "label": "", "metadata": {}, "score": "72.45978"}
{"text": "2007 , 6 : 27 - 10.1186/1744 - 859X-6 - 27 .PubMed Central PubMed .Nivoli AM , Colom F , Murru A , Pacchiarotti I , Castro - Loli P , Gonzalez - Pinto A , Fountoulakis KN , Vieta E : New treatment guidelines for acute bipolar depression : a systematic review .", "label": "", "metadata": {}, "score": "72.48801"}
{"text": "The results showed significant improvements in symptoms when participants used chlorella as compared to placebo .Note : There are serious safety concerns about blue - green algae .", "label": "", "metadata": {}, "score": "72.54122"}
{"text": "Effects of mud - bath treatment on fibromyalgia patients : a randomized clinical trial .Rheumatol Int .2007 May 23 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "72.56431"}
{"text": "Albanese MJ , Pies R. The bipolar patient with comorbid substance use disorder : recognition and management .CNS Drugs .Kupfer DJ , Frank E , Grochocinski VJ , et al .", "label": "", "metadata": {}, "score": "72.987595"}
{"text": "10.4088/JCP.v67n1105 .PubMed .Nemeroff CB , Evans DL , Gyulai L , Sachs GS , Bowden CL , Gergel IP , Oakes R , Pitts CD : Double - blind , placebo - controlled comparison of imipramine and paroxetine in the treatment of bipolar depression .", "label": "", "metadata": {}, "score": "73.04518"}
{"text": "10.1016/j.biopsych.2006.02.034 .PubMed .Calabrese JR , Vieta E , Shelton MD : Latest maintenance data on lamotrigine in bipolar disorder .Eur Neuropsychopharmacol .", "label": "", "metadata": {}, "score": "73.06966"}
{"text": "The finding that coadministration of NAC significantly increased absti- nence even in this context is striking .It is thus tempting to argue that , by extension , NAC would enhance cessation outcomes on its own or when added to other psychosocial treatments .", "label": "", "metadata": {}, "score": "73.130615"}
{"text": "Those who used the real treatment reported less tenderness in their tender points than those using the placebo .Interestingly , the points on their untreated sides were also less tender .", "label": "", "metadata": {}, "score": "73.200424"}
{"text": "R , ? Ford?HL , ? Vitolo?SA , ?Doebrick?CA , ?Rounsaville?BJ : ? The?use?of ? contingency ? management ? and ? motivational / skills : ? building ? therapy?to?treat?young?adults?with?marijuana?dependence .", "label": "", "metadata": {}, "score": "73.22904"}
{"text": "Wang C , Schmid C , Rones R , et al .A randomized trial of Tai Chi for fibromyalgia .N Engl J Med .", "label": "", "metadata": {}, "score": "73.35146"}
{"text": "Cusin C , Serretti A , Lattuada E , et al .Impact of clinical variables on illness time course in mood disorders .Psychiatry Res .", "label": "", "metadata": {}, "score": "73.386505"}
{"text": "Recurrence in affective disorder , I : case register study .Br J Psychiatry .Yatham LN .Atypical antipsychotics for bipolar disorder .Psychiatr Clin North Am .", "label": "", "metadata": {}, "score": "73.39789"}
{"text": "10.4088/JCP.v66n0308 .PubMed .Okuma T , Inanaga K , Otsuki S , Sarai K , Takahashi R , Hazama H , Mori A , Watanabe S : A preliminary double - blind study on the efficacy of carbamazepine in prophylaxis of manic - depressive illness .", "label": "", "metadata": {}, "score": "73.40501"}
{"text": "Bukstein in an editorial ( p. 771 ) notes that N - acetylcysteine is being in- vestigated for a wide range of psychiatric illnesses .Its up - regulation of the cysteine- glutamate exchanger may have widespread brain effects , because glutamate is the brain 's most commonly used neurotransmitter .", "label": "", "metadata": {}, "score": "73.41025"}
{"text": "10.1176/appi.ajp.160.9.1651 .PubMed .J Psychopharmacol .PubMed .J Affect Disord .10.1016/j.jad.2008.05.014 .PubMed .Garcia - Amador M , Pacchiarotti I , Valenti M , Sanchez RF , Goikolea JM , Vieta E : Role of aripiprazole in treating mood disorders .", "label": "", "metadata": {}, "score": "73.61254"}
{"text": "10.1016/j.jad.2007.10.016 .PubMed .Fountoulakis KN , Magiria S , Siamouli M , Panagiotidis P , Nimatoudis I , Iacovides A , Kaprinis GS : A seven - year follow - up of an extremely refractory bipolar I patient .", "label": "", "metadata": {}, "score": "73.65988"}
{"text": "Adverse events oc- curring in at least two participants and deemed at least possibly treatment related included vivid dreams ( three in the NAC group ) , insomnia ( three in the placebo group ) , and irritability ( two in the placebo group ) .", "label": "", "metadata": {}, "score": "73.80505"}
{"text": "PubMed .Lloyd AJ , Harrison CL , Ferrier IN , Young AH : The pharmacological treatment of bipolar affective disorder : practice is improving but could still be better .", "label": "", "metadata": {}, "score": "73.80679"}
{"text": "Zubsolv also demonstrated no increased rate of withdrawal symptoms or opioid cravings versus Suboxone film at day 15 and day 22 .The safety profile of Zubsolv was similar to that of Suboxone film .", "label": "", "metadata": {}, "score": "73.86387"}
{"text": "If , at a given visit , a participant tested positive but adhered to study procedures , he or she collected the adher- ence reward as scheduled but was not eligible for the abstinence reward .", "label": "", "metadata": {}, "score": "73.92538"}
{"text": "However , it is not known if one or both of these actions by NAC is needed to inhibit relapse to cocaine seeking .To determine whether the restoration of GLT-1 and/or cystine - glutamate exchange is required for NAC to inhibit cue - induced reinstatement of cocaine seeking , we utilized the rat self - administration / extinction / reinstatement model of cocaine relapse .", "label": "", "metadata": {}, "score": "73.970955"}
{"text": "2008 May 22 .Brosseau L , Wells GA , Tugwell P , et al .Ottawa panel evidence - based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia : part 2 .", "label": "", "metadata": {}, "score": "73.981705"}
{"text": "10.1016/j.jad.2005.02.018 .PubMed .Parker G , Tully L , Olley A , Hadzi - Pavlovic D : SSRIs as mood stabilizers for bipolar II disorder ?", "label": "", "metadata": {}, "score": "73.9819"}
{"text": "10.4088/JCP.v67n1003 .PubMed .J Clin Psychiatry .10.4088/JCP.v69n1113 .PubMed .Emrich HM , von Zerssen D , Kissling W , Moller HJ , Windorfer A : Effect of sodium valproate on mania .", "label": "", "metadata": {}, "score": "73.98524"}
{"text": "It is not clear whether SAMe is helping fibromyalgia through antidepressant effects or some other mechanism .For more information , including dosage and safety issues , see the full SAMe article .", "label": "", "metadata": {}, "score": "74.065125"}
{"text": "10.1176/appi.ps.58.1.85 .Wilting I , Souverein PC , Nolen WA , Egberts AC , Heerdink ER : Changes in outpatient lithium treatment in the Netherlands during 1996 - 2005 .", "label": "", "metadata": {}, "score": "74.07654"}
{"text": "Archiv fur Psychiatrie und Nervenkrankheiten .10.1007/BF00343800 .PubMed .Emrich HM , von Zerssen D , Kissling W , Moller HJ : Therapeutic effect of valproate in mania .", "label": "", "metadata": {}, "score": "74.08869"}
{"text": "Proc?Natl?Acad?Sci ?USA ?Reichel?CM , ?Moussawi?K , ?Do?PH , ? Kalivas?PW , ?See?RE : ?Chronic ?N - acetylcysteine ? during?abstinence?or?extinction?after?cocaine ? self - administration ? produces ? enduring ? reductions ? in ? drug ? seeking .", "label": "", "metadata": {}, "score": "74.100845"}
{"text": "ler?E , ?Hergueta?T , ?Baker?R , ?Dunbar?GC : ?The?Mini - Interna- tional?Neuropsychiatric?Interview ?( MINI ) : ? the?development?and ?validation?of?a?structured?diagnostic?psychiatric?interview?for ?", "label": "", "metadata": {}, "score": "74.10352"}
{"text": "10.1017/S0033291700003068 .PubMed .Prien RF , Kupfer DJ , Mansky PA , Small JG , Tuason VB , Voss CB , Johnson WE : Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders .", "label": "", "metadata": {}, "score": "74.11522"}
{"text": "( NAC ) ?in?young?marijuana?users : ? an?open - label?pilot?study .Am?J?Addict ?Carroll?KM , ?Easton?CJ , ? Nich?C , ?Hunkele?KA , ? Neavins?TM , ?", "label": "", "metadata": {}, "score": "74.20758"}
{"text": "SENSE confirmed the safety , tolerability and efficacy .The most common adverse events were dizziness , insomnia and nausea and the treatment effect of nalmefene was maintained and improved after one year of treatment .", "label": "", "metadata": {}, "score": "74.349594"}
{"text": "10.1176/appi.ajp.161.1.169 .PubMed .Olanzapine HGEH Study Group .Am J Psychiatry .PubMed .The Olanzipine HGGW Study Group .Arch Gen Psychiatry .", "label": "", "metadata": {}, "score": "74.38869"}
{"text": "Brosseau L , Wells GA , Tugwell P , et al .Ottawa panel evidence - based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia : part 1 .", "label": "", "metadata": {}, "score": "74.420746"}
{"text": "J Clin Psychiatry .Yatham LN .Brain imaging investigations of dopaminergic pathways in mood disorders .In : Soares JC , ed .Brain Imaging in Affective Disorders .", "label": "", "metadata": {}, "score": "74.59813"}
{"text": "If such a situation exists , and patients usually receive treatment according to a ' class effect ' , it has huge implications for public health and also for the overall cost of mental disorders , and especially for bipolar disorder .", "label": "", "metadata": {}, "score": "74.685684"}
{"text": "Data from randomized clinical trials .CNS Neurosci Ther .Oshima A , Higuchi T , Fujiwara Y , Iida M , Iwanami A , Kanba S , Motohashi N , Uchitomi Y , Yamada K , Yamawaki S : Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders .", "label": "", "metadata": {}, "score": "74.766556"}
{"text": "Osteopathic manipulative therapy , which focuses on manual treatment of the musculoskeletal system , has some evidence to support its use as a treatment for fibromyalgia .", "label": "", "metadata": {}, "score": "74.899734"}
{"text": "Deluze C , Bosia L , Zirbs A , Chantraine A , Vischer TL .Electroacupuncture in fibromyalgia : results of a controlled trial .BMJ .", "label": "", "metadata": {}, "score": "75.1888"}
{"text": "Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Investigator , Outcomes Assessor ) Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "75.41548"}
{"text": "Valproate as a loading treatment in acute mania .Neuropsychobiology .Keck PE Jr , McElroy SL , Tugrul KC , Bennett JA .Valproate oral loading in the treatment of acute mania .", "label": "", "metadata": {}, "score": "75.658905"}
{"text": "Official Title : .Dose - dependent Drug - drug Interaction Between Paracetamol and Warfarin in Adults Receiving Long - term Oral Anticoagulants : A Randomized Controlled Trial .", "label": "", "metadata": {}, "score": "75.678925"}
{"text": "The pharmacological basis for DSF 's use in alcohol addiction is its ability to inhibit liver mitochondrial aldehyde dehydrogenase ( ALDH 2 ) [ 1].", "label": "", "metadata": {}, "score": "75.75995"}
{"text": "Synthetic Biologics is actively planning a phase III program for SYN-010 .December 14 , 2015 .Astellas Pharma and Ironwood Pharmaceuticals released results of a phase III trial of linaclotide conducted in Japan in adults with irritable bowel syndrome with constipation ( IBS - C ) .", "label": "", "metadata": {}, "score": "75.760345"}
{"text": "1994;23(suppl 3):41 - 47 .Merchant RE , Andre CA .A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia , hypertension , and ulcerative colitis .", "label": "", "metadata": {}, "score": "75.817024"}
{"text": "Clin Exp Rheumatol .Busch AJ , Schachter CL , Overend TJ , et al .Exercise for fibromyalgia : a systematic review .J Rheumatol .", "label": "", "metadata": {}, "score": "76.05314"}
{"text": "Jacobus?J , ?Bava?S , ?Cohen - Zion ?M , ?Mahmood?O , ?Tapert?SF : ? Func- tional?consequences?of?marijuana?use?in?adolescents . Pharma- col?Biochem?Behav ?Compton?WM , ?", "label": "", "metadata": {}, "score": "76.354"}
{"text": "Jager?G , ? Ramsey?NF : ?Long - term ?consequences?of?adolescent ? cannabis ? exposure ? on ? the ? development ? of ? cognition , ? brain ? structure , ? and?function : ? an?overview?of?animal?and?human?re- search .", "label": "", "metadata": {}, "score": "76.37645"}
{"text": "From a clinical point of view , depression and the maintenance phase seem to be more important since effective treatments are much fewer in comparison to acute mania .", "label": "", "metadata": {}, "score": "76.38559"}
{"text": "Restoring GLT-1 , not cystine - glutamate exchange , is a key mechanism whereby daily NAC reduces cue - induced cocaine reinstatement .Additional , prospective trials are urgently needed to assess the potential role of glutamate modulators , such as NAC , in youth with anxiety disorders , including those who have had partial responses to ' ' first - line ' ' psychopharmacologic and psychotherapeutic interventions . \"", "label": "", "metadata": {}, "score": "76.68129"}
{"text": "The observation period for safety will continue for 24 hours following the final dose of study drug .Males and females who are at least 18 and no more than 65 years of age .", "label": "", "metadata": {}, "score": "76.754654"}
{"text": "Concomitant medication and completion rates .The examination of concomitant medications is important because they may produce a confounding effect on efficacy measures .For example , hypnotics may help patients sleep better at night , thus reducing the YMRS score for sleep .", "label": "", "metadata": {}, "score": "76.85358"}
{"text": "For the majority of missing data assignments that could be reasonably expected , the odds ratio remained significant .In general , the selection of missing data handling method had little effect on analytic outcomes .", "label": "", "metadata": {}, "score": "76.867195"}
{"text": "Colbert AP , Markov MS , Banerji M , et al .Magnetic mattress pad use in patients with fibromyalgia : a randomized double - blind pilot study .", "label": "", "metadata": {}, "score": "77.0677"}
{"text": "58 Overall , the results do not provide reliable evidence that acupuncture is helpful .Other alternative treatments with minimal supporting evidence include : .The martial art Tai Chi has also been studied as a treatment for fibromylgia .", "label": "", "metadata": {}, "score": "77.07568"}
{"text": "Since a presumed ' class effect ' is a very frequent and not adequately studied factor behind pharmaceutical prescription , the results of the current study suggest that a significant number of patients worldwide may not receive proper treatment .", "label": "", "metadata": {}, "score": "77.41072"}
{"text": "Williams?JBW : ? Structured?Clini- cal?Interview?for?DSM - IV?Axis?I?Disorders ?( SCID ) .New?York , ?New ?York?State?Psychiatric?Institute , ? Biometrics?Research , ?Sobell?LC , ?", "label": "", "metadata": {}, "score": "77.58708"}
{"text": "Secondary endpoints , including Drug High and Good Effects , chewing duration , taste / texture assessments and safety assessments , were generally the same consistency of effects observed in the primary endpoints .", "label": "", "metadata": {}, "score": "77.64624"}
{"text": "I : ?end-points?and?treatments .Lancet ?Moore?RA , ? Aubin?HJ : ? Do?placebo?response?rates?from?cessation ? trials?inform?on?strength?of?addictions ? ?Int?J?Environ?Res?Public ? Health ?Hollis?S : ?", "label": "", "metadata": {}, "score": "77.65367"}
{"text": "Linaclotide is a guanylate cyclase - C ( GC - C ) agonist currently approved in the U.S. for the treatment of adults with IBS - C and chronic idiopathic constipation ( CIC ) .", "label": "", "metadata": {}, "score": "77.68459"}
{"text": "two?randomized?trials .J?Subst?Abuse?Treat ?Waldron ?HB , ?Turner ?CW : ?Evidence - based ? psychosocial ? treat- ments?for?adolescent?substance?abuse .J?Clin?Child?Adolesc?Psy- chol ?", "label": "", "metadata": {}, "score": "77.796555"}
{"text": "3,4 The social consequences are also high .More than 65 % of patients have difficulty in maintaining long - term relationships and 60 % have troubled relationships with their children .", "label": "", "metadata": {}, "score": "77.89238"}
{"text": "Int J Obes ( Lond ) .Knox JM .A study of weight reducing diets in psychiatric in - patients .Br J Psychiatry .", "label": "", "metadata": {}, "score": "78.05346"}
{"text": "10.1016/j.jad.2007.08.018 .PubMed .Akiskal HS : The prevalent clinical spectrum of bipolar disorders : beyond DSM - IV .J Clin Psychopharmacol .", "label": "", "metadata": {}, "score": "78.13063"}
{"text": "Its release profile appears to be well - suited to use with a chronic pain population .Based on these results , Pain Therapeutics plans to move development of PTI-202 into phase II trials .", "label": "", "metadata": {}, "score": "78.1886"}
{"text": "Biol?Psychiatry ?Zhou ?W , ?Kalivas ?PW : ? N - acetylcysteine ? reduces ? extinction ? re-sponding?and?induces?enduring?reductions?in?cue- ? and?heroin- induced?drug - seeking .", "label": "", "metadata": {}, "score": "78.20546"}
{"text": "Dermatology precautions and slower titration yield low incidence of lamotrigine treatment - emergent rash .J Clin Psychiatry .Nguyen C , Jensen B , Franklin D , et al .", "label": "", "metadata": {}, "score": "78.463844"}
{"text": "No violations of the assumption were determined .No adjustments for multiple testing were made , as they are known to reduce statistical power and increase the probabil- ity of accepting a null hypothesis that is truly false .", "label": "", "metadata": {}, "score": "78.46695"}
{"text": "Furthermore , the study 's strict criteria for mania ( MRS score of 16 or higher or need for hospitalization ) and depression ( antidepressant use or discontinuation from the study because of symptoms ) may have reduced the power of the analysis .", "label": "", "metadata": {}, "score": "78.54144"}
{"text": "However , recently there was important insight into the illness with the description and definition of subtypes ( BD - I to BD - VI ) [ 1 - 3 ] .", "label": "", "metadata": {}, "score": "78.71585"}
{"text": "ZR has received speaker 's honoraria from AstraZeneca , GlaxoSmithKline , Lilly , Lundbeck , Organon , Pfizer , Richter , Sanofi - Aventis , Servier - EGIS , and Wyeth Pharmaceuticals .", "label": "", "metadata": {}, "score": "78.732925"}
{"text": "J Rheumatol .Sverdrup B. Use less cosmetics - suffer less from fibromyalgia ?J Womens Health ( Larchmt ) .Jones KD , Adams D , Winters - Stone K , Burckhardt CS .", "label": "", "metadata": {}, "score": "78.75188"}
{"text": "October 4 , 2004 .Nabi Biopharmaceuticals issued positive phase II results for NicVAX , their nicotine conjugate vaccine for the promotion of smoking cessation .", "label": "", "metadata": {}, "score": "78.767204"}
{"text": "Other symptoms commonly believed to be associated with fibromyalgia are irritable bowel syndrome , urinary frequency , anxiety , headache , and numbness or tingling .", "label": "", "metadata": {}, "score": "78.93986"}
{"text": "It must be noted , however , that it is hard to believe the study was really double - blind , since it is impossible to hide the burning sensation caused by capsaicin !", "label": "", "metadata": {}, "score": "79.00506"}
{"text": "Smith WA .Fibromyalgia syndrome .Nurs Clin North Am .Alfano AP , Taylor AG , Foresman PA , et al .Static magnetic fields for treatment of fibromyalgia : a randomized controlled trial .", "label": "", "metadata": {}, "score": "79.08763"}
{"text": "NIH?Publication?No ?Rockville , ?Md , ?National ?Institutes?of?Health , ?Kalachnik?JE : ? Standardized?Monitoring?for?Psychopharmaco- logic?Medication?Side?Effects : ? Manual?for?the?Monitoring?of ? Side?Effects?Scale ?( MOSES ) .", "label": "", "metadata": {}, "score": "79.10096"}
{"text": "38The 3-week trial involved 329 patients with nonpsychotic acute mania and showed no differences in YMRS scores or response rates between the 2 groups .", "label": "", "metadata": {}, "score": "79.27348"}
{"text": "Drug?Alcohol?Depend ?Sheehan ?DV , ?Lecrubier ?Y , ?Sheehan ?KH , ?Amorim ?P , ?Janavs ?J , ?", "label": "", "metadata": {}, "score": "79.378876"}
{"text": "The study proce- dures were approved by the university institutional review board and were in accord with the Helsinki Declaration of 1975 .Recruitment occurred primarily through clinical referrals and local media ( e.g. , flyers , newspaper announcements , online ad- vertisements ) .", "label": "", "metadata": {}, "score": "79.55182"}
{"text": "10.1016/j.jad.2010.05.018 .PubMed .Fountoulakis KN : An update of evidence - based treatment of bipolar depression : where do we stand ?Curr Opin Psychiatry .", "label": "", "metadata": {}, "score": "79.690865"}
{"text": "Studies have shown that many pharmacologic agents are effective in the treatment of acute mania and bipolar relapse education .Bipolar disorder is the sixth leading cause of medical disability worldwide for persons aged 15 to 44 years .", "label": "", "metadata": {}, "score": "79.75632"}
{"text": "There were no reports of diarrhea .Plecanatide treatment exhibited a good safety profile and no severe adverse events were observed .September 20 , 2010 .", "label": "", "metadata": {}, "score": "79.98291"}
{"text": "61 Craniosacral therapy involves manipulating external tissues of the head .This is done to help facilitate the natural rhythmic pulsation , which are thought to travel through brain and spinal cord .", "label": "", "metadata": {}, "score": "80.07297"}
{"text": "American Psychiatric Association .Practice guideline for the treatment of patients with bipolar disorder .2nd ed . cfm .Accessed November 15 , 2006 .", "label": "", "metadata": {}, "score": "80.82761"}
{"text": "A single - blind study of somewhat convoluted design provides weak evidence that a gown made from a special \" electromagnetic shielding fabric \" can reduce fibromyalgia symptoms .", "label": "", "metadata": {}, "score": "80.96127"}
{"text": "SPA therapy in fibromyalgia : a randomised controlled clinic study .Rheumatol Int .Rossini M , Di Munno O , Valentini G et al .", "label": "", "metadata": {}, "score": "81.06947"}
{"text": "Working correlation structures were indepen- dently compared , and the final model structure was chosen us- ing the quasi - likelihood under the independence model criterion ( 34 ) .", "label": "", "metadata": {}, "score": "81.09154"}
{"text": "For each successive visit at which the participant was adherent or abstinent , the reward increased by $ 2 ( $ 7 , then $ 9 , and so on ) .", "label": "", "metadata": {}, "score": "81.40873"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT00734461 Addictions .June 22 , 2015 .", "label": "", "metadata": {}, "score": "81.43887"}
{"text": "Thus , a review of the literature was judged to be necessary .If the opposite were the , case the table would rely on arbitrary opinion and could be misleading .", "label": "", "metadata": {}, "score": "81.44453"}
{"text": "The subject is willing and able to speak , read , and understand English and provide written informed consent .The subject 's urine drug screen and ethanol breath test are negative at check - in to the clinic .", "label": "", "metadata": {}, "score": "81.78568"}
{"text": "The subject has any significant deviations from normal in physical examination , electrocardiogram ( ECG ) , or clinical laboratory tests , as evaluated by the investigator .", "label": "", "metadata": {}, "score": "82.03867"}
{"text": "Am?J?Psychiatry ?Mardikian?PN , ?LaRowe?SD , ?Hedden?S , ? Kalivas?PW , ?Malcolm?RJ : ?An?open - label?trial?of?N - acetylcysteine?for?the?treatment?of?co- caine?dependence : ? a?pilot?study .", "label": "", "metadata": {}, "score": "82.29252"}
{"text": "Selincro was generally well tolerated over 52 weeks .The most frequent adverse events included dizziness , insomnia and nausea .June 20 , 2011 .", "label": "", "metadata": {}, "score": "82.3754"}
{"text": "Top .Bottom .The average lever responses during the last 3 sessions of cocaine self administration ( left ) and the lever responses during a cue - induced relapse test 30 min after intra - dmPFC infusion ( right ) .", "label": "", "metadata": {}, "score": "82.65132"}
{"text": "What is impressive is the lack of any class effect concerning antiepileptics .This has been reported previously [ 136 ] , and it is very interesting because anecdotal reports suggest that the average clinician considers the term ' antiepileptic ' to be more or less interchangeable with ' mood stabilizer ' .", "label": "", "metadata": {}, "score": "82.68912"}
{"text": "Background .In the last decade there were important developments in our understanding of bipolar disorder ( BD ) , as well as its treatment .", "label": "", "metadata": {}, "score": "83.07741"}
{"text": "Health Qual Life Outcomes .Accessed October 2 , 2006 .K , Lammi K , Hypen M , et al .Vegan diet alleviates fibromyalgia symptoms .", "label": "", "metadata": {}, "score": "83.41721"}
{"text": "ZR contributed to the interpretation of results and commented on following drafts .Authors ' Affiliations .Third Department of Psychiatry , School of Medicine , Aristotle University of Thessaloniki .", "label": "", "metadata": {}, "score": "83.4815"}
{"text": "( Neuropharmacology , 2013 , 75C , 95 - 105 ) is discussed .Copyright \u00a9 2015 Elsevier B.V. All rights reserved .Full - text \u00b7 Article \u00b7 Jan 2015 \u00b7 Journal of Pharmaceutical and Biomedical Analysis .", "label": "", "metadata": {}, "score": "83.90871"}
{"text": "The significance threshold was set at a p value of 0.05 ( two - sided ) .Results Participants were enrolled between September 2009 and January 2011 .", "label": "", "metadata": {}, "score": "83.940895"}
{"text": "J Clin Rheumatol .Offenbacher M , Stucki G. Physical therapy in the treatment of fibromyalgia .Scand J Rheumatol Suppl .Brattberg G. Connective tissue massage in the treatment of fibromyalgia .", "label": "", "metadata": {}, "score": "84.342445"}
{"text": "Neither conclusion is confirmed by newer studies ; however , since these conclusions were widely accepted for decades , these old agents are considered to be the ' gold standard ' and ' class effects ' were suggested to exist .", "label": "", "metadata": {}, "score": "84.47602"}
{"text": "Angst J : The emerging epidemiology of hypomania and bipolar II disorder .J Affect Disord .10.1016/S0165 - 0327(98)00142 - 6 .PubMed .", "label": "", "metadata": {}, "score": "84.74343"}
{"text": "Bach GL , Clement DB .Efficacy of Farabloc as an analgesic in primary fibromyalgia .Clin Rheumatol .2007 Jan 11 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "84.91893"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "84.93254"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "84.93254"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "85.1293"}
{"text": "mate?exchange?in?nicotine?dependence?in?rats?and?humans .Biol?Psychiatry ? Amen?SL , ? Piacentine?LB , ?Ahmad?ME , ?Li?SJ , ? Mantsch?JR , ?Rising- er?RC , ?Baker?DA : ?", "label": "", "metadata": {}, "score": "85.15749"}
{"text": "information?criterion?in?generalized?estimat- ing?equations .Biometrics ? Rothman?KJ : ? No?adjustments?are?needed?for?multiple?compari- sons .Epidemiology ?Feise?R : ?Do?multiple?outcome?measures?require?p - value?ad- justment ? ?BMC?Med?Res?Methodol ? Schulz?KF , ? Grimes?DA : ?", "label": "", "metadata": {}, "score": "85.53703"}
{"text": "Volkow?ND : ?New?medications?for?drug?addiction ? hiding?in?glutamatergic?neuroplasticity . Mol?Psychiatry ?Olive ?MF , ?Cleva ?RM , ?Kalivas ?PW , ?Malcolm ?", "label": "", "metadata": {}, "score": "85.584305"}
{"text": "Conclusions .In the treatment of bipolar disorder , a pharmaceutical class effect is the exception rather than the rule , and such class effects concern only acute mania and antipsychotics .", "label": "", "metadata": {}, "score": "85.70614"}
{"text": "The assumption of proportional hazards was assessed by including an interaction between the treatment group assignment variable and the log - transformed time - to- event variable .", "label": "", "metadata": {}, "score": "86.094406"}
{"text": "PubMed .World Health Organization : The World Health Report 2003 - Shaping The Future .2003 , Geneva , Switzerland : WHO .Fountoulakis KN , Grunze H , Panagiotidis P , Kaprinis G : Treatment of bipolar depression : an update .", "label": "", "metadata": {}, "score": "86.14139"}
{"text": "Acceptable methods of birth control include surgical sterilization , hormonal contraceptives , or double - barrier methods ( condom or diaphragm with a spermicidal agent or intrauterine device [ IUD ] ) .", "label": "", "metadata": {}, "score": "86.79579"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Both pre - clinical and clinical studies indicate that N - acetylcysteine ( NAC ) may be useful in treating relapse to addictive drug use .", "label": "", "metadata": {}, "score": "86.93443"}
{"text": "J Neurol .2005 Feb 23 .[ Epub ahead of print ] .Astin JA , Berman BM , Bausell B , et al .", "label": "", "metadata": {}, "score": "86.94485"}
{"text": "Department?of?Pediatrics , ?School?of?Medicine , ? Univer- sity?of?South?Carolina ; ? and?Columbia , ?South?Carolina?Depart- ment?of?Disabilities?and?Special?Needs , ? Moeller?FG , ? Schmitz?JM , ? Steinberg?JL , ?", "label": "", "metadata": {}, "score": "87.00215"}
{"text": "Donaldson ?J , ?Liddle?H , ? Titus?JC , ?Kaminer?Y , ?Webb?C , ? Hamilton?N , ?Funk?R : ?The?Cannabis?Youth?Treatment ?( CYT ) ? study : ?", "label": "", "metadata": {}, "score": "87.45671"}
{"text": "Adverse event rates were compared between treatment groups using Pearson 's chi - square tests .Study completion was compared using logistic regression .Cox proportional hazards regression was used to assess the effect of demographic and clinical charac- teristics and treatment assignment on time to study dropout .", "label": "", "metadata": {}, "score": "87.52811"}
{"text": "However , it is highly likely that a significant number of patients worldwide are not receiving proper treatment simply because the ' class effect ' idea discourages continued scientific training and reading .", "label": "", "metadata": {}, "score": "87.58395"}
{"text": "Assessing potential health risks from microcystin toxins in blue - green algae dietary supplements .Environ Health Perspect .Islam MS , Rahim Z , Alam MJ , et al .", "label": "", "metadata": {}, "score": "87.847694"}
{"text": "10.1016/j.jad.2009.10.033 .PubMed .Divalproex Maintenance Study Group .Arch Gen Psychiatry .10.1001/archpsyc.57.5.481 .PubMed .Ballenger JC , Post RM :", "label": "", "metadata": {}, "score": "88.09071"}
{"text": "Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "88.218"}
{"text": "Ann Behav Med .Rossy LA , Buckelew SP , Dorr N , et al .A meta - analysis of fibromyalgia treatment interventions .Ann Behav Med .", "label": "", "metadata": {}, "score": "88.24814"}
{"text": "10.1111/j.1399 -5618.2006.00276.x .PubMed .Klein DF : Importance of psychiatric diagnosis in prediction of clinical drug effects .Arch Gen Psychiatry .", "label": "", "metadata": {}, "score": "88.584946"}
{"text": "PubMed .Copyright .\u00a9 Fountoulakis et al ; licensee BioMed Central Ltd. 2011 .This article is published under license to BioMed Central Ltd.Allocation : Randomized Endpoint Classification : Safety Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Caregiver , Investigator )", "label": "", "metadata": {}, "score": "88.96898"}
{"text": "The mechanism of action of DSF for treating these addictions is unclear but it is unlikely to involve the inhibition of liver aldehyde dehydrogenase ( ALDH2 ) .", "label": "", "metadata": {}, "score": "89.29998"}
{"text": "Dr. Carpenter 's effort was supported by NIDA grant K23DA020482 .The authors thank the adolescents and families who participated in the study and acknowledge the tremendous contributions of the clinical research team , including Sarah Farber , Jessica Lydiard , and Christine Horne .", "label": "", "metadata": {}, "score": "89.5728"}
{"text": "For more information , including dosage and safety issues , see the full 5-HTP article .Capsaicin , the \" hot \" in cayenne peppers , is widely used as a treatment for various painful conditions , such as shingles and arthritis .", "label": "", "metadata": {}, "score": "90.11444"}
{"text": "References .Murray CJ , Lopez AD .Global mortality , disability , and the contribution of risk factors : Global Burden of Disease Study .", "label": "", "metadata": {}, "score": "90.24075"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT01104337 .Antiphospholipid Syndrome Atrial Fibrillation Pulmonary Embolism Venous Thromboembolism Venous Thrombosis Arrhythmias , Cardiac Autoimmune Diseases Cardiovascular Diseases Embolism Embolism and Thrombosis Heart Diseases Immune System Diseases Lung Diseases Pathologic Processes Respiratory Tract Diseases .", "label": "", "metadata": {}, "score": "90.537735"}
{"text": "Related Medical Areas .This information does not represent a Lupus Research Institute endorsement of any listed study .It is merely a notice that the study is available .", "label": "", "metadata": {}, "score": "90.76206"}
{"text": "Authors ' contributions .KNF conducted the literature search , interpreted the results and wrote the first draft , and commented on following drafts .XG contributed to the interpretation of results , wrote subsequent drafts .", "label": "", "metadata": {}, "score": "90.910446"}
{"text": "Department of Clinical and Theoretical Mental Health , Faculty of Medicine , Semmelweis University .Bipolar Disorders Program , Hospital Clinic , IDIBAPS , CIBERSAM , University of Barcelona .", "label": "", "metadata": {}, "score": "91.15996"}
{"text": "Astellas expects to submit a new drug application to the Ministry of Health , Labor and Welfare in Japan in 2016 .October 26 , 2015 .", "label": "", "metadata": {}, "score": "91.491135"}
{"text": "Safety will be monitored by vital signs ( heart rate , blood pressure , respiratory rate , and pulse oximetry ) , adverse events assessments , clinical laboratory tests , physical examinations and electrocardiograms ( ECGs ) .", "label": "", "metadata": {}, "score": "91.527664"}
{"text": "10.1016/S0140 - 6736(10)60570 - 3 .PubMed .Fountoulakis KN : The BALANCE trial .Lancet .10.1016/S0140 - 6736(10)60569 - 7 .", "label": "", "metadata": {}, "score": "92.32823"}
{"text": "10.1016/j.jad.2008.01.019 .PubMed .Kovacs G : Pharmacotherapeutic trends at the beginning of the millennium in Hungary .Pharmacotherapy for bipolar patients , I. [ in Hungarian].", "label": "", "metadata": {}, "score": "92.328384"}
{"text": "10.4088/JCP.v65n0321 .PubMed .Frye MA , Ketter TA , Kimbrell TA , Dunn RT , Speer AM , Osuch EA , Luckenbaugh DA , Cora - Ocatelli G , Leverich GS , Post RM :", "label": "", "metadata": {}, "score": "92.48128"}
{"text": "Address correspondence to Dr. Gray ( graykm@musc.edu ) .Dr. Gray has received research funding from Merck and Supernus Pharmaceuticals .Dr. Hartwell has received research funding from Pfizer .", "label": "", "metadata": {}, "score": "92.979225"}
{"text": "J?Clin?Psychiatry ?59(suppl ? Sheehan?DV , ?Sheehan?KH , ?Shytle?RD , ?Janavs?J , ?Bannon?Y , ?Rog- ers?JE , ? Milo?KM , ? Stock?SL , ?", "label": "", "metadata": {}, "score": "92.9826"}
{"text": "References .Croft P , Schollum J , Silman A. Population study of tender point counts and pain as evidence of fibromyalgia .BMJ .Fauci AS , Braunwald E , Isselbacher KJ , et al , eds .", "label": "", "metadata": {}, "score": "93.79184"}
{"text": "J Affect Disord .10.1016/S0165 - 0327(02)00332 - 4 . PubMed .Acorn S : Mental and physical health of homeless persons who use emergency shelters in Vancouver .", "label": "", "metadata": {}, "score": "96.72578"}
{"text": "Because of this , some physicians are inclined to believe that the condition is \" all in the patient 's head .\" One researcher has noted that many of the symptoms of fibromyalgia , including certain tender points , are common in the general population , and goes so far as to question whether it is a real condition .", "label": "", "metadata": {}, "score": "97.00675"}
{"text": "Pouria S , de Andrade A , Barbosa J , et al .Fatal microcystin intoxication in haemodialysis unit in Caruaru , Brazil .Lancet .", "label": "", "metadata": {}, "score": "97.514694"}
{"text": "10.1017/S1461145701002565 .PubMed .Lecrubier Y , Bech P : The Ham D(6 ) is more homogenous and as sensitive as the Ham D(17 ) .", "label": "", "metadata": {}, "score": "97.798965"}
{"text": "Received Jan. 13 , 2012 ; revisions received March 7 and April 3 , 2012 ; accepted April 6 , 2012 ( doi : 10.1176/appi.ajp.2012.12010055 ) .", "label": "", "metadata": {}, "score": "98.478714"}
{"text": "Johnston?LD , ? O'Malley ?PM , ? Bachman?JG , ?Schulenberg?JE : ? Moni-toring?the?Future : ? National?Results?on?Adolescent?Drug?Use : ? Overview?of?Key?Findings , ?Ann?Arbor , ?", "label": "", "metadata": {}, "score": "99.96703"}
{"text": "Do not contact the Lupus Research Institute for information on these studies .Only contact the listed numbers .The Lupus Research Institute does not have any jurisdiction over or further involvement with these studies , other than to make people aware that they are being conducted .", "label": "", "metadata": {}, "score": "100.43515"}
{"text": "Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition .", "label": "", "metadata": {}, "score": "101.34417"}
{"text": "Fibromyalgia is a common chronic condition whose main symptoms are specific tender points on various parts of the body , widespread musculoskeletal discomfort , morning stiffness , fatigue , and disturbed sleep .", "label": "", "metadata": {}, "score": "101.79637"}
{"text": "outcome .Stat ?Med ? Gray?KM , ? Carpenter?MJ , ?Baker?NL , ?Hartwell?KJ , ?Lewis?AL , ?Hiott ?DW , ? Deas?D , ?", "label": "", "metadata": {}, "score": "101.8863"}
{"text": "Conclusions .The available data suggest that a ' class effect ' is the exception rather than the rule in the treatment of BD .However , the possible presence of a ' class effect ' concept discourages clinicians from continued scientific training and reading .", "label": "", "metadata": {}, "score": "102.97612"}
{"text": "Knackstedt?LA , ?LaRowe?S , ?Mardikian?P , ?Malcolm?R , ?Upadhyaya ?H , ?Hedden?S , ?Markou?A , ?Kalivas?P : ?", "label": "", "metadata": {}, "score": "103.508804"}
{"text": "14th ed .New York , NY : McGraw - Hill ; 1998 .Rossy LA , Buckelew SP , Dorr N , et al .", "label": "", "metadata": {}, "score": "103.62119"}
{"text": "0.146 17.2 20.9 19.4 20.9 Mean -41.1 -37.0 SD 28.2 28.5 Mean Differ- ence ( SEM ) -4.0 ( 6.0 ) 95 % CIp -15.8 to 7.9 0.512 .", "label": "", "metadata": {}, "score": "105.45777"}
{"text": "Please be aware that this information is provided to supplement the care provided by your physician .It is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "107.97958"}
{"text": "SAMe , short for S - adenosylmethionine , is a chemical derived from a combination of methionine , an amino acid , and adenosine triphosphate ( ATP ) , the main molecule for energy in the body .", "label": "", "metadata": {}, "score": "112.60347"}
{"text": "LaRowe?SD , ? Myrick?H , ?Hedden?S , ?Mardikian?P , ?Saladin?M , ? McRae ?A , ?Brady?K , ? Kalivas?PW , ?", "label": "", "metadata": {}, "score": "112.76491"}
{"text": "10.1034/j.1399 -5618.2001.30505.x .PubMed .Br J Psychiatry .10.1192/bjp.bp.105.013045 .PubMed .J Clin Psychiatry .10.4088/JCP.08m04191 .", "label": "", "metadata": {}, "score": "112.95708"}
{"text": "J Clin Psychiatry .10.4088/JCP.v60n0203 .PubMed .J Clin Psychiatry .10.4088/JCP.08m04152 .PubMed .Arch Gen Psychiatry .10.1001/archpsyc.60.4.392 .", "label": "", "metadata": {}, "score": "113.55028"}
